AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|EVENT_TYPE|POPULATION|SITE|YEAR
0-14|0.3|0.4|0.3|194|Mortality|59955368|Acute Lymphocytic|1999
0-14|3.4|3.7|3.5|2076|Incidence|59151007|Acute Lymphocytic|1999
0-14|0.2|0.3|0.2|141|Mortality|59955368|Acute Myeloid|1999
0-14|0.6|0.7|0.7|399|Incidence|59151007|Acute Myeloid|1999
0-14|2.4|2.6|2.5|1498|Mortality|59955368|All Cancer Sites Combined|1999
0-14|14.2|14.9|14.5|8582|Incidence|59151007|All Cancer Sites Combined|1999
0-14|0.1|0.2|0.1|82|Mortality|59955368|Bones and Joints|1999
0-14|0.7|0.8|0.7|434|Incidence|59151007|Bones and Joints|1999
0-14|0.7|0.8|0.7|431|Mortality|59955368|Brain and Other Nervous System|1999
0-14|3.1|3.4|3.3|1933|Incidence|59151007|Brain and Other Nervous System|1999
0-14|~|~|~|~|Mortality|59955368|Hodgkin Lymphoma|1999
0-14|0.5|0.6|0.5|324|Incidence|59151007|Hodgkin Lymphoma|1999
0-14|0.1|0.1|0.1|54|Mortality|59955368|Kidney and Renal Pelvis|1999
0-14|0.8|0.9|0.8|494|Incidence|59151007|Kidney and Renal Pelvis|1999
0-14|0.7|0.8|0.8|451|Mortality|59955368|Leukemia|1999
0-14|4.3|4.7|4.5|2661|Incidence|59151007|Leukemia|1999
0-14|0.1|0.1|0.1|55|Mortality|59955368|Non-Hodgkin Lymphoma|1999
0-14|0.8|1.0|0.9|526|Incidence|59151007|Non-Hodgkin Lymphoma|1999
0-14|0.5|0.6|0.5|328|Mortality|59955368|Other|1999
0-14|2.8|3.1|2.9|1715|Incidence|59151007|Other|1999
0-14|0.1|0.2|0.1|87|Mortality|59955368|Soft Tissue|1999
0-14|0.8|0.9|0.8|495|Incidence|59151007|Soft Tissue|1999
0-19|0.3|0.4|0.4|285|Mortality|80039970|Acute Lymphocytic|1999
0-19|2.8|3.1|3.0|2341|Incidence|78936986|Acute Lymphocytic|1999
0-19|0.2|0.3|0.3|207|Mortality|80039970|Acute Myeloid|1999
0-19|0.7|0.8|0.7|570|Incidence|78936986|Acute Myeloid|1999
0-19|2.7|2.9|2.8|2243|Mortality|80039970|All Cancer Sites Combined|1999
0-19|15.6|16.1|15.8|12472|Incidence|78936986|All Cancer Sites Combined|1999
0-19|0.2|0.3|0.3|209|Mortality|80039970|Bones and Joints|1999
0-19|0.8|1.0|0.9|709|Incidence|78936986|Bones and Joints|1999
0-19|0.6|0.7|0.7|546|Mortality|80039970|Brain and Other Nervous System|1999
0-19|2.8|3.1|3.0|2334|Incidence|78936986|Brain and Other Nervous System|1999
0-19|0.0|0.1|0.1|41|Mortality|80039970|Hodgkin Lymphoma|1999
0-19|1.1|1.3|1.2|934|Incidence|78936986|Hodgkin Lymphoma|1999
0-19|0.1|0.1|0.1|62|Mortality|80039970|Kidney and Renal Pelvis|1999
0-19|0.6|0.7|0.7|523|Incidence|78936986|Kidney and Renal Pelvis|1999
0-19|0.8|0.9|0.8|672|Mortality|80039970|Leukemia|1999
0-19|3.9|4.2|4.0|3187|Incidence|78936986|Leukemia|1999
0-19|0.1|0.2|0.1|106|Mortality|80039970|Non-Hodgkin Lymphoma|1999
0-19|1.0|1.1|1.1|834|Incidence|78936986|Non-Hodgkin Lymphoma|1999
0-19|0.5|0.6|0.6|455|Mortality|80039970|Other|1999
0-19|4.0|4.3|4.1|3259|Incidence|78936986|Other|1999
0-19|0.2|0.2|0.2|152|Mortality|80039970|Soft Tissue|1999
0-19|0.8|0.9|0.9|692|Incidence|78936986|Soft Tissue|1999
0-14|0.3|0.4|0.4|234|Mortality|60279841|Acute Lymphocytic|2000
0-14|3.5|3.8|3.7|2164|Incidence|59476204|Acute Lymphocytic|2000
0-14|0.2|0.3|0.2|145|Mortality|60279841|Acute Myeloid|2000
0-14|0.5|0.7|0.6|353|Incidence|59476204|Acute Myeloid|2000
0-14|2.4|2.7|2.5|1526|Mortality|60279841|All Cancer Sites Combined|2000
0-14|14.6|15.2|14.9|8849|Incidence|59476204|All Cancer Sites Combined|2000
0-14|0.1|0.2|0.1|83|Mortality|60279841|Bones and Joints|2000
0-14|0.6|0.7|0.7|401|Incidence|59476204|Bones and Joints|2000
0-14|0.7|0.8|0.7|440|Mortality|60279841|Brain and Other Nervous System|2000
0-14|3.2|3.5|3.4|2003|Incidence|59476204|Brain and Other Nervous System|2000
0-14|~|~|~|~|Mortality|60279841|Hodgkin Lymphoma|2000
0-14|0.5|0.7|0.6|350|Incidence|59476204|Hodgkin Lymphoma|2000
0-14|0.1|0.1|0.1|46|Mortality|60279841|Kidney and Renal Pelvis|2000
0-14|0.8|1.0|0.9|530|Incidence|59476204|Kidney and Renal Pelvis|2000
0-14|0.7|0.9|0.8|490|Mortality|60279841|Leukemia|2000
0-14|4.4|4.8|4.6|2718|Incidence|59476204|Leukemia|2000
0-14|0.1|0.1|0.1|55|Mortality|60279841|Non-Hodgkin Lymphoma|2000
0-14|0.9|1.0|0.9|557|Incidence|59476204|Non-Hodgkin Lymphoma|2000
0-14|0.5|0.6|0.6|333|Mortality|60279841|Other|2000
0-14|2.8|3.0|2.9|1718|Incidence|59476204|Other|2000
0-14|0.1|0.1|0.1|71|Mortality|60279841|Soft Tissue|2000
0-14|0.9|1.0|1.0|572|Incidence|59476204|Soft Tissue|2000
0-19|0.4|0.5|0.4|332|Mortality|80574796|Acute Lymphocytic|2000
0-19|3.0|3.3|3.1|2483|Incidence|79474943|Acute Lymphocytic|2000
0-19|0.2|0.3|0.3|222|Mortality|80574796|Acute Myeloid|2000
0-19|0.6|0.7|0.7|521|Incidence|79474943|Acute Myeloid|2000
0-19|2.7|2.9|2.8|2271|Mortality|80574796|All Cancer Sites Combined|2000
0-19|16.1|16.6|16.3|12963|Incidence|79474943|All Cancer Sites Combined|2000
0-19|0.2|0.3|0.2|181|Mortality|80574796|Bones and Joints|2000
0-19|0.8|0.9|0.9|678|Incidence|79474943|Bones and Joints|2000
0-19|0.6|0.7|0.7|545|Mortality|80574796|Brain and Other Nervous System|2000
0-19|3.0|3.2|3.1|2438|Incidence|79474943|Brain and Other Nervous System|2000
0-19|0.0|0.1|0.0|29|Mortality|80574796|Hodgkin Lymphoma|2000
0-19|1.2|1.3|1.2|984|Incidence|79474943|Hodgkin Lymphoma|2000
0-19|0.1|0.1|0.1|54|Mortality|80574796|Kidney and Renal Pelvis|2000
0-19|0.6|0.8|0.7|558|Incidence|79474943|Kidney and Renal Pelvis|2000
0-19|0.8|1.0|0.9|732|Mortality|80574796|Leukemia|2000
0-19|4.0|4.3|4.1|3266|Incidence|79474943|Leukemia|2000
0-19|0.1|0.2|0.1|115|Mortality|80574796|Non-Hodgkin Lymphoma|2000
0-19|1.1|1.2|1.1|909|Incidence|79474943|Non-Hodgkin Lymphoma|2000
0-19|0.5|0.6|0.6|471|Mortality|80574796|Other|2000
0-19|4.0|4.3|4.2|3308|Incidence|79474943|Other|2000
0-19|0.2|0.2|0.2|144|Mortality|80574796|Soft Tissue|2000
0-19|1.0|1.1|1.0|822|Incidence|79474943|Soft Tissue|2000
0-14|0.3|0.4|0.3|208|Mortality|60450257|Acute Lymphocytic|2001
0-14|3.6|4.0|3.8|2253|Incidence|59815030|Acute Lymphocytic|2001
0-14|0.2|0.3|0.3|157|Mortality|60450257|Acute Myeloid|2001
0-14|0.6|0.7|0.7|395|Incidence|59815030|Acute Myeloid|2001
0-14|2.4|2.6|2.5|1494|Mortality|60450257|All Cancer Sites Combined|2001
0-14|15.3|15.9|15.6|9330|Incidence|59815030|All Cancer Sites Combined|2001
0-14|0.1|0.2|0.1|88|Mortality|60450257|Bones and Joints|2001
0-14|0.7|0.8|0.7|434|Incidence|59815030|Bones and Joints|2001
0-14|0.6|0.8|0.7|416|Mortality|60450257|Brain and Other Nervous System|2001
0-14|3.2|3.5|3.4|2003|Incidence|59815030|Brain and Other Nervous System|2001
0-14|~|~|~|~|Mortality|60450257|Hodgkin Lymphoma|2001
0-14|0.5|0.7|0.6|357|Incidence|59815030|Hodgkin Lymphoma|2001
0-14|0.1|0.1|0.1|58|Mortality|60450257|Kidney and Renal Pelvis|2001
0-14|0.8|1.0|0.9|528|Incidence|59815030|Kidney and Renal Pelvis|2001
0-14|0.8|0.9|0.8|503|Mortality|60450257|Leukemia|2001
0-14|4.7|5.0|4.8|2882|Incidence|59815030|Leukemia|2001
0-14|0.0|0.1|0.1|40|Mortality|60450257|Non-Hodgkin Lymphoma|2001
0-14|0.8|1.0|0.9|543|Incidence|59815030|Non-Hodgkin Lymphoma|2001
0-14|0.4|0.6|0.5|297|Mortality|60450257|Other|2001
0-14|3.2|3.5|3.3|1997|Incidence|59815030|Other|2001
0-14|0.1|0.2|0.1|86|Mortality|60450257|Soft Tissue|2001
0-14|0.9|1.1|1.0|586|Incidence|59815030|Soft Tissue|2001
0-19|0.3|0.4|0.4|313|Mortality|80906541|Acute Lymphocytic|2001
0-19|3.1|3.4|3.2|2560|Incidence|80042731|Acute Lymphocytic|2001
0-19|0.2|0.3|0.3|227|Mortality|80906541|Acute Myeloid|2001
0-19|0.7|0.8|0.7|568|Incidence|80042731|Acute Myeloid|2001
0-19|2.6|2.9|2.8|2226|Mortality|80906541|All Cancer Sites Combined|2001
0-19|16.8|17.3|17.1|13651|Incidence|80042731|All Cancer Sites Combined|2001
0-19|0.2|0.3|0.2|189|Mortality|80906541|Bones and Joints|2001
0-19|0.9|1.0|1.0|783|Incidence|80042731|Bones and Joints|2001
0-19|0.6|0.7|0.6|520|Mortality|80906541|Brain and Other Nervous System|2001
0-19|2.9|3.2|3.1|2443|Incidence|80042731|Brain and Other Nervous System|2001
0-19|0.0|0.1|0.0|31|Mortality|80906541|Hodgkin Lymphoma|2001
0-19|1.2|1.3|1.3|1007|Incidence|80042731|Hodgkin Lymphoma|2001
0-19|0.1|0.1|0.1|66|Mortality|80906541|Kidney and Renal Pelvis|2001
0-19|0.6|0.8|0.7|561|Incidence|80042731|Kidney and Renal Pelvis|2001
0-19|0.8|1.0|0.9|728|Mortality|80906541|Leukemia|2001
0-19|4.2|4.5|4.3|3462|Incidence|80042731|Leukemia|2001
0-19|0.1|0.2|0.1|101|Mortality|80906541|Non-Hodgkin Lymphoma|2001
0-19|1.0|1.2|1.1|900|Incidence|80042731|Non-Hodgkin Lymphoma|2001
0-19|0.5|0.6|0.6|444|Mortality|80906541|Other|2001
0-19|4.4|4.7|4.6|3685|Incidence|80042731|Other|2001
0-19|0.2|0.2|0.2|147|Mortality|80906541|Soft Tissue|2001
0-19|0.9|1.1|1.0|810|Incidence|80042731|Soft Tissue|2001
0-14|0.3|0.4|0.4|217|Mortality|60563030|Acute Lymphocytic|2002
0-14|3.5|3.8|3.6|2161|Incidence|59931314|Acute Lymphocytic|2002
0-14|0.2|0.3|0.2|131|Mortality|60563030|Acute Myeloid|2002
0-14|0.6|0.7|0.7|407|Incidence|59931314|Acute Myeloid|2002
0-14|2.4|2.7|2.6|1548|Mortality|60563030|All Cancer Sites Combined|2002
0-14|15.2|15.8|15.5|9288|Incidence|59931314|All Cancer Sites Combined|2002
0-14|0.1|0.2|0.1|85|Mortality|60563030|Bones and Joints|2002
0-14|0.6|0.8|0.7|430|Incidence|59931314|Bones and Joints|2002
0-14|0.7|0.8|0.8|463|Mortality|60563030|Brain and Other Nervous System|2002
0-14|3.4|3.7|3.5|2118|Incidence|59931314|Brain and Other Nervous System|2002
0-14|~|~|~|~|Mortality|60563030|Hodgkin Lymphoma|2002
0-14|0.5|0.6|0.5|335|Incidence|59931314|Hodgkin Lymphoma|2002
0-14|0.1|0.1|0.1|42|Mortality|60563030|Kidney and Renal Pelvis|2002
0-14|0.8|0.9|0.9|508|Incidence|59931314|Kidney and Renal Pelvis|2002
0-14|0.7|0.8|0.7|441|Mortality|60563030|Leukemia|2002
0-14|4.6|4.9|4.7|2818|Incidence|59931314|Leukemia|2002
0-14|0.1|0.2|0.1|74|Mortality|60563030|Non-Hodgkin Lymphoma|2002
0-14|0.8|1.0|0.9|539|Incidence|59931314|Non-Hodgkin Lymphoma|2002
0-14|0.5|0.6|0.6|342|Mortality|60563030|Other|2002
0-14|3.1|3.4|3.2|1935|Incidence|59931314|Other|2002
0-14|0.1|0.2|0.2|95|Mortality|60563030|Soft Tissue|2002
0-14|0.9|1.1|1.0|605|Incidence|59931314|Soft Tissue|2002
0-19|0.4|0.4|0.4|323|Mortality|81173400|Acute Lymphocytic|2002
0-19|3.0|3.2|3.1|2488|Incidence|80317363|Acute Lymphocytic|2002
0-19|0.2|0.3|0.3|209|Mortality|81173400|Acute Myeloid|2002
0-19|0.7|0.8|0.7|575|Incidence|80317363|Acute Myeloid|2002
0-19|2.7|2.9|2.8|2271|Mortality|81173400|All Cancer Sites Combined|2002
0-19|16.8|17.4|17.1|13724|Incidence|80317363|All Cancer Sites Combined|2002
0-19|0.2|0.3|0.2|179|Mortality|81173400|Bones and Joints|2002
0-19|0.9|1.0|0.9|759|Incidence|80317363|Bones and Joints|2002
0-19|0.7|0.8|0.7|571|Mortality|81173400|Brain and Other Nervous System|2002
0-19|3.1|3.3|3.2|2571|Incidence|80317363|Brain and Other Nervous System|2002
0-19|0.0|0.1|0.0|33|Mortality|81173400|Hodgkin Lymphoma|2002
0-19|1.2|1.3|1.2|1003|Incidence|80317363|Hodgkin Lymphoma|2002
0-19|0.0|0.1|0.1|49|Mortality|81173400|Kidney and Renal Pelvis|2002
0-19|0.6|0.7|0.7|536|Incidence|80317363|Kidney and Renal Pelvis|2002
0-19|0.8|0.9|0.8|678|Mortality|81173400|Leukemia|2002
0-19|4.1|4.4|4.2|3392|Incidence|80317363|Leukemia|2002
0-19|0.1|0.2|0.1|118|Mortality|81173400|Non-Hodgkin Lymphoma|2002
0-19|1.1|1.2|1.1|912|Incidence|80317363|Non-Hodgkin Lymphoma|2002
0-19|0.6|0.7|0.6|490|Mortality|81173400|Other|2002
0-19|4.5|4.8|4.6|3727|Incidence|80317363|Other|2002
0-19|0.2|0.2|0.2|153|Mortality|81173400|Soft Tissue|2002
0-19|1.0|1.1|1.0|824|Incidence|80317363|Soft Tissue|2002
0-14|0.4|0.5|0.4|246|Mortality|60628650|Acute Lymphocytic|2003
0-14|3.4|3.7|3.6|2141|Incidence|60628650|Acute Lymphocytic|2003
0-14|0.2|0.3|0.2|142|Mortality|60628650|Acute Myeloid|2003
0-14|0.6|0.7|0.7|397|Incidence|60628650|Acute Myeloid|2003
0-14|2.4|2.7|2.5|1543|Mortality|60628650|All Cancer Sites Combined|2003
0-14|14.9|15.5|15.2|9233|Incidence|60628650|All Cancer Sites Combined|2003
0-14|0.1|0.2|0.1|82|Mortality|60628650|Bones and Joints|2003
0-14|0.6|0.8|0.7|420|Incidence|60628650|Bones and Joints|2003
0-14|0.7|0.8|0.8|458|Mortality|60628650|Brain and Other Nervous System|2003
0-14|3.2|3.5|3.4|2030|Incidence|60628650|Brain and Other Nervous System|2003
0-14|~|~|~|~|Mortality|60628650|Hodgkin Lymphoma|2003
0-14|0.5|0.6|0.6|360|Incidence|60628650|Hodgkin Lymphoma|2003
0-14|0.1|0.1|0.1|54|Mortality|60628650|Kidney and Renal Pelvis|2003
0-14|0.8|0.9|0.9|524|Incidence|60628650|Kidney and Renal Pelvis|2003
0-14|0.8|0.9|0.8|505|Mortality|60628650|Leukemia|2003
0-14|4.4|4.7|4.5|2739|Incidence|60628650|Leukemia|2003
0-14|0.1|0.1|0.1|50|Mortality|60628650|Non-Hodgkin Lymphoma|2003
0-14|0.8|1.0|0.9|545|Incidence|60628650|Non-Hodgkin Lymphoma|2003
0-14|0.5|0.6|0.5|311|Mortality|60628650|Other|2003
0-14|3.2|3.5|3.3|2031|Incidence|60628650|Other|2003
0-14|0.1|0.2|0.1|78|Mortality|60628650|Soft Tissue|2003
0-14|0.9|1.0|1.0|584|Incidence|60628650|Soft Tissue|2003
0-19|0.4|0.4|0.4|328|Mortality|81425816|Acute Lymphocytic|2003
0-19|2.9|3.1|3.0|2438|Incidence|81425816|Acute Lymphocytic|2003
0-19|0.2|0.3|0.3|207|Mortality|81425816|Acute Myeloid|2003
0-19|0.6|0.7|0.7|563|Incidence|81425816|Acute Myeloid|2003
0-19|2.6|2.9|2.7|2233|Mortality|81425816|All Cancer Sites Combined|2003
0-19|16.5|17.0|16.8|13685|Incidence|81425816|All Cancer Sites Combined|2003
0-19|0.2|0.3|0.2|186|Mortality|81425816|Bones and Joints|2003
0-19|0.8|1.0|0.9|732|Incidence|81425816|Bones and Joints|2003
0-19|0.7|0.8|0.7|577|Mortality|81425816|Brain and Other Nervous System|2003
0-19|3.0|3.2|3.1|2495|Incidence|81425816|Brain and Other Nervous System|2003
0-19|0.0|0.0|0.0|21|Mortality|81425816|Hodgkin Lymphoma|2003
0-19|1.2|1.3|1.2|1025|Incidence|81425816|Hodgkin Lymphoma|2003
0-19|0.1|0.1|0.1|65|Mortality|81425816|Kidney and Renal Pelvis|2003
0-19|0.6|0.7|0.7|555|Incidence|81425816|Kidney and Renal Pelvis|2003
0-19|0.8|0.9|0.8|688|Mortality|81425816|Leukemia|2003
0-19|3.9|4.2|4.1|3301|Incidence|81425816|Leukemia|2003
0-19|0.1|0.2|0.1|103|Mortality|81425816|Non-Hodgkin Lymphoma|2003
0-19|1.0|1.2|1.1|881|Incidence|81425816|Non-Hodgkin Lymphoma|2003
0-19|0.5|0.6|0.6|447|Mortality|81425816|Other|2003
0-19|4.5|4.8|4.7|3860|Incidence|81425816|Other|2003
0-19|0.2|0.2|0.2|146|Mortality|81425816|Soft Tissue|2003
0-19|1.0|1.1|1.0|836|Incidence|81425816|Soft Tissue|2003
0-14|0.3|0.4|0.3|202|Mortality|60651802|Acute Lymphocytic|2004
0-14|3.7|4.0|3.8|2322|Incidence|60651802|Acute Lymphocytic|2004
0-14|0.2|0.3|0.2|147|Mortality|60651802|Acute Myeloid|2004
0-14|0.6|0.8|0.7|421|Incidence|60651802|Acute Myeloid|2004
0-14|2.3|2.6|2.5|1492|Mortality|60651802|All Cancer Sites Combined|2004
0-14|15.7|16.3|16.0|9737|Incidence|60651802|All Cancer Sites Combined|2004
0-14|0.1|0.2|0.1|75|Mortality|60651802|Bones and Joints|2004
0-14|0.7|0.8|0.7|451|Incidence|60651802|Bones and Joints|2004
0-14|0.7|0.8|0.7|446|Mortality|60651802|Brain and Other Nervous System|2004
0-14|3.5|3.8|3.6|2183|Incidence|60651802|Brain and Other Nervous System|2004
0-14|~|~|~|~|Mortality|60651802|Hodgkin Lymphoma|2004
0-14|0.5|0.6|0.5|324|Incidence|60651802|Hodgkin Lymphoma|2004
0-14|0.1|0.1|0.1|51|Mortality|60651802|Kidney and Renal Pelvis|2004
0-14|0.8|0.9|0.8|508|Incidence|60651802|Kidney and Renal Pelvis|2004
0-14|0.7|0.8|0.8|455|Mortality|60651802|Leukemia|2004
0-14|4.8|5.1|4.9|2989|Incidence|60651802|Leukemia|2004
0-14|0.1|0.1|0.1|44|Mortality|60651802|Non-Hodgkin Lymphoma|2004
0-14|0.9|1.0|0.9|575|Incidence|60651802|Non-Hodgkin Lymphoma|2004
0-14|0.5|0.6|0.5|317|Mortality|60651802|Other|2004
0-14|3.3|3.6|3.4|2097|Incidence|60651802|Other|2004
0-14|0.1|0.2|0.2|98|Mortality|60651802|Soft Tissue|2004
0-14|0.9|1.1|1.0|610|Incidence|60651802|Soft Tissue|2004
0-19|0.3|0.4|0.4|295|Mortality|81754354|Acute Lymphocytic|2004
0-19|3.2|3.4|3.3|2665|Incidence|81754354|Acute Lymphocytic|2004
0-19|0.2|0.3|0.3|211|Mortality|81754354|Acute Myeloid|2004
0-19|0.7|0.8|0.7|596|Incidence|81754354|Acute Myeloid|2004
0-19|2.6|2.8|2.7|2223|Mortality|81754354|All Cancer Sites Combined|2004
0-19|17.2|17.7|17.4|14332|Incidence|81754354|All Cancer Sites Combined|2004
0-19|0.2|0.3|0.2|189|Mortality|81754354|Bones and Joints|2004
0-19|0.9|1.0|0.9|771|Incidence|81754354|Bones and Joints|2004
0-19|0.6|0.7|0.7|555|Mortality|81754354|Brain and Other Nervous System|2004
0-19|3.2|3.4|3.3|2678|Incidence|81754354|Brain and Other Nervous System|2004
0-19|0.0|0.0|0.0|23|Mortality|81754354|Hodgkin Lymphoma|2004
0-19|1.1|1.3|1.2|992|Incidence|81754354|Hodgkin Lymphoma|2004
0-19|0.1|0.1|0.1|59|Mortality|81754354|Kidney and Renal Pelvis|2004
0-19|0.6|0.7|0.7|550|Incidence|81754354|Kidney and Renal Pelvis|2004
0-19|0.8|0.9|0.8|665|Mortality|81754354|Leukemia|2004
0-19|4.3|4.6|4.4|3595|Incidence|81754354|Leukemia|2004
0-19|0.1|0.1|0.1|100|Mortality|81754354|Non-Hodgkin Lymphoma|2004
0-19|1.0|1.2|1.1|921|Incidence|81754354|Non-Hodgkin Lymphoma|2004
0-19|0.5|0.6|0.6|468|Mortality|81754354|Other|2004
0-19|4.6|4.9|4.8|3965|Incidence|81754354|Other|2004
0-19|0.2|0.2|0.2|164|Mortality|81754354|Soft Tissue|2004
0-19|1.0|1.1|1.0|860|Incidence|81754354|Soft Tissue|2004
0-14|0.3|0.4|0.3|188|Mortality|60519046|Acute Lymphocytic|2005
0-14|3.6|3.9|3.7|2254|Incidence|60519046|Acute Lymphocytic|2005
0-14|0.2|0.3|0.2|137|Mortality|60519046|Acute Myeloid|2005
0-14|0.6|0.7|0.6|390|Incidence|60519046|Acute Myeloid|2005
0-14|2.3|2.5|2.4|1452|Mortality|60519046|All Cancer Sites Combined|2005
0-14|15.3|15.9|15.6|9489|Incidence|60519046|All Cancer Sites Combined|2005
0-14|0.1|0.2|0.1|88|Mortality|60519046|Bones and Joints|2005
0-14|0.6|0.8|0.7|420|Incidence|60519046|Bones and Joints|2005
0-14|0.6|0.8|0.7|426|Mortality|60519046|Brain and Other Nervous System|2005
0-14|3.3|3.6|3.4|2064|Incidence|60519046|Brain and Other Nervous System|2005
0-14|~|~|~|~|Mortality|60519046|Hodgkin Lymphoma|2005
0-14|0.5|0.7|0.6|360|Incidence|60519046|Hodgkin Lymphoma|2005
0-14|0.1|0.1|0.1|54|Mortality|60519046|Kidney and Renal Pelvis|2005
0-14|0.8|0.9|0.9|519|Incidence|60519046|Kidney and Renal Pelvis|2005
0-14|0.6|0.8|0.7|417|Mortality|60519046|Leukemia|2005
0-14|4.6|4.9|4.7|2882|Incidence|60519046|Leukemia|2005
0-14|0.1|0.1|0.1|55|Mortality|60519046|Non-Hodgkin Lymphoma|2005
0-14|0.8|1.0|0.9|550|Incidence|60519046|Non-Hodgkin Lymphoma|2005
0-14|0.5|0.6|0.5|318|Mortality|60519046|Other|2005
0-14|3.3|3.5|3.4|2083|Incidence|60519046|Other|2005
0-14|0.1|0.2|0.1|83|Mortality|60519046|Soft Tissue|2005
0-14|0.9|1.1|1.0|611|Incidence|60519046|Soft Tissue|2005
0-19|0.3|0.4|0.3|267|Mortality|82005260|Acute Lymphocytic|2005
0-19|3.0|3.3|3.2|2585|Incidence|82005260|Acute Lymphocytic|2005
0-19|0.2|0.3|0.3|212|Mortality|82005260|Acute Myeloid|2005
0-19|0.6|0.7|0.7|545|Incidence|82005260|Acute Myeloid|2005
0-19|2.5|2.8|2.7|2183|Mortality|82005260|All Cancer Sites Combined|2005
0-19|17.0|17.6|17.3|14273|Incidence|82005260|All Cancer Sites Combined|2005
0-19|0.2|0.3|0.3|212|Mortality|82005260|Bones and Joints|2005
0-19|0.8|1.0|0.9|749|Incidence|82005260|Bones and Joints|2005
0-19|0.6|0.7|0.7|544|Mortality|82005260|Brain and Other Nervous System|2005
0-19|3.0|3.2|3.1|2543|Incidence|82005260|Brain and Other Nervous System|2005
0-19|0.0|0.0|0.0|22|Mortality|82005260|Hodgkin Lymphoma|2005
0-19|1.2|1.4|1.3|1070|Incidence|82005260|Hodgkin Lymphoma|2005
0-19|0.1|0.1|0.1|62|Mortality|82005260|Kidney and Renal Pelvis|2005
0-19|0.6|0.8|0.7|568|Incidence|82005260|Kidney and Renal Pelvis|2005
0-19|0.7|0.8|0.8|640|Mortality|82005260|Leukemia|2005
0-19|4.1|4.4|4.2|3478|Incidence|82005260|Leukemia|2005
0-19|0.1|0.1|0.1|102|Mortality|82005260|Non-Hodgkin Lymphoma|2005
0-19|1.1|1.2|1.2|964|Incidence|82005260|Non-Hodgkin Lymphoma|2005
0-19|0.5|0.6|0.5|438|Mortality|82005260|Other|2005
0-19|4.7|5.0|4.8|4040|Incidence|82005260|Other|2005
0-19|0.2|0.2|0.2|163|Mortality|82005260|Soft Tissue|2005
0-19|1.0|1.1|1.0|861|Incidence|82005260|Soft Tissue|2005
0-14|0.2|0.3|0.3|174|Mortality|60516709|Acute Lymphocytic|2006
0-14|3.7|4.0|3.9|2343|Incidence|60516709|Acute Lymphocytic|2006
0-14|0.2|0.2|0.2|124|Mortality|60516709|Acute Myeloid|2006
0-14|0.6|0.8|0.7|420|Incidence|60516709|Acute Myeloid|2006
0-14|2.1|2.4|2.2|1360|Mortality|60516709|All Cancer Sites Combined|2006
0-14|15.6|16.2|15.9|9691|Incidence|60516709|All Cancer Sites Combined|2006
0-14|0.1|0.1|0.1|59|Mortality|60516709|Bones and Joints|2006
0-14|0.7|0.8|0.7|439|Incidence|60516709|Bones and Joints|2006
0-14|0.6|0.8|0.7|422|Mortality|60516709|Brain and Other Nervous System|2006
0-14|3.4|3.7|3.5|2134|Incidence|60516709|Brain and Other Nervous System|2006
0-14|~|~|~|~|Mortality|60516709|Hodgkin Lymphoma|2006
0-14|0.6|0.7|0.6|373|Incidence|60516709|Hodgkin Lymphoma|2006
0-14|0.1|0.1|0.1|43|Mortality|60516709|Kidney and Renal Pelvis|2006
0-14|0.8|0.9|0.9|522|Incidence|60516709|Kidney and Renal Pelvis|2006
0-14|0.6|0.7|0.7|411|Mortality|60516709|Leukemia|2006
0-14|4.8|5.1|4.9|3000|Incidence|60516709|Leukemia|2006
0-14|0.1|0.1|0.1|44|Mortality|60516709|Non-Hodgkin Lymphoma|2006
0-14|0.8|1.0|0.9|550|Incidence|60516709|Non-Hodgkin Lymphoma|2006
0-14|0.4|0.5|0.5|296|Mortality|60516709|Other|2006
0-14|3.2|3.5|3.4|2075|Incidence|60516709|Other|2006
0-14|0.1|0.2|0.1|80|Mortality|60516709|Soft Tissue|2006
0-14|0.9|1.1|1.0|598|Incidence|60516709|Soft Tissue|2006
0-19|0.3|0.4|0.3|266|Mortality|82324418|Acute Lymphocytic|2006
0-19|3.2|3.4|3.3|2700|Incidence|82324418|Acute Lymphocytic|2006
0-19|0.2|0.3|0.2|195|Mortality|82324418|Acute Myeloid|2006
0-19|0.7|0.8|0.7|597|Incidence|82324418|Acute Myeloid|2006
0-19|2.4|2.6|2.5|2035|Mortality|82324418|All Cancer Sites Combined|2006
0-19|17.1|17.6|17.4|14408|Incidence|82324418|All Cancer Sites Combined|2006
0-19|0.2|0.2|0.2|174|Mortality|82324418|Bones and Joints|2006
0-19|0.9|1.0|1.0|796|Incidence|82324418|Bones and Joints|2006
0-19|0.6|0.7|0.6|524|Mortality|82324418|Brain and Other Nervous System|2006
0-19|3.1|3.4|3.2|2645|Incidence|82324418|Brain and Other Nervous System|2006
0-19|0.0|0.0|0.0|23|Mortality|82324418|Hodgkin Lymphoma|2006
0-19|1.2|1.3|1.3|1059|Incidence|82324418|Hodgkin Lymphoma|2006
0-19|0.1|0.1|0.1|54|Mortality|82324418|Kidney and Renal Pelvis|2006
0-19|0.6|0.8|0.7|570|Incidence|82324418|Kidney and Renal Pelvis|2006
0-19|0.7|0.8|0.7|618|Mortality|82324418|Leukemia|2006
0-19|4.3|4.6|4.4|3653|Incidence|82324418|Leukemia|2006
0-19|0.1|0.1|0.1|89|Mortality|82324418|Non-Hodgkin Lymphoma|2006
0-19|1.1|1.2|1.1|946|Incidence|82324418|Non-Hodgkin Lymphoma|2006
0-19|0.5|0.6|0.5|413|Mortality|82324418|Other|2006
0-19|4.5|4.8|4.6|3911|Incidence|82324418|Other|2006
0-19|0.1|0.2|0.2|140|Mortality|82324418|Soft Tissue|2006
0-19|0.9|1.1|1.0|828|Incidence|82324418|Soft Tissue|2006
0-14|0.3|0.4|0.4|212|Mortality|60681615|Acute Lymphocytic|2007
0-14|3.8|4.1|4.0|2412|Incidence|60681615|Acute Lymphocytic|2007
0-14|0.2|0.3|0.2|129|Mortality|60681615|Acute Myeloid|2007
0-14|0.6|0.7|0.7|414|Incidence|60681615|Acute Myeloid|2007
0-14|2.2|2.4|2.3|1395|Mortality|60681615|All Cancer Sites Combined|2007
0-14|15.9|16.6|16.2|9929|Incidence|60681615|All Cancer Sites Combined|2007
0-14|0.1|0.1|0.1|61|Mortality|60681615|Bones and Joints|2007
0-14|0.6|0.8|0.7|427|Incidence|60681615|Bones and Joints|2007
0-14|0.6|0.8|0.7|426|Mortality|60681615|Brain and Other Nervous System|2007
0-14|3.5|3.8|3.7|2225|Incidence|60681615|Brain and Other Nervous System|2007
0-14|~|~|~|~|Mortality|60681615|Hodgkin Lymphoma|2007
0-14|0.5|0.6|0.5|333|Incidence|60681615|Hodgkin Lymphoma|2007
0-14|0.0|0.1|0.1|36|Mortality|60681615|Kidney and Renal Pelvis|2007
0-14|0.8|1.0|0.9|543|Incidence|60681615|Kidney and Renal Pelvis|2007
0-14|0.7|0.8|0.7|441|Mortality|60681615|Leukemia|2007
0-14|4.8|5.2|5.0|3057|Incidence|60681615|Leukemia|2007
0-14|0.0|0.1|0.1|40|Mortality|60681615|Non-Hodgkin Lymphoma|2007
0-14|0.9|1.1|1.0|596|Incidence|60681615|Non-Hodgkin Lymphoma|2007
0-14|0.4|0.6|0.5|306|Mortality|60681615|Other|2007
0-14|3.2|3.5|3.4|2093|Incidence|60681615|Other|2007
0-14|0.1|0.2|0.1|82|Mortality|60681615|Soft Tissue|2007
0-14|1.0|1.2|1.1|655|Incidence|60681615|Soft Tissue|2007
0-19|0.3|0.4|0.4|294|Mortality|82749431|Acute Lymphocytic|2007
0-19|3.3|3.5|3.4|2778|Incidence|82749431|Acute Lymphocytic|2007
0-19|0.2|0.3|0.2|195|Mortality|82749431|Acute Myeloid|2007
0-19|0.6|0.8|0.7|583|Incidence|82749431|Acute Myeloid|2007
0-19|2.4|2.6|2.5|2068|Mortality|82749431|All Cancer Sites Combined|2007
0-19|17.5|18.0|17.8|14836|Incidence|82749431|All Cancer Sites Combined|2007
0-19|0.2|0.2|0.2|172|Mortality|82749431|Bones and Joints|2007
0-19|0.8|1.0|0.9|753|Incidence|82749431|Bones and Joints|2007
0-19|0.6|0.7|0.6|521|Mortality|82749431|Brain and Other Nervous System|2007
0-19|3.2|3.4|3.3|2724|Incidence|82749431|Brain and Other Nervous System|2007
0-19|0.0|0.0|0.0|19|Mortality|82749431|Hodgkin Lymphoma|2007
0-19|1.1|1.3|1.2|1041|Incidence|82749431|Hodgkin Lymphoma|2007
0-19|0.0|0.1|0.1|47|Mortality|82749431|Kidney and Renal Pelvis|2007
0-19|0.7|0.8|0.7|587|Incidence|82749431|Kidney and Renal Pelvis|2007
0-19|0.7|0.8|0.8|643|Mortality|82749431|Leukemia|2007
0-19|4.3|4.6|4.5|3708|Incidence|82749431|Leukemia|2007
0-19|0.1|0.1|0.1|87|Mortality|82749431|Non-Hodgkin Lymphoma|2007
0-19|1.1|1.2|1.2|977|Incidence|82749431|Non-Hodgkin Lymphoma|2007
0-19|0.5|0.6|0.5|439|Mortality|82749431|Other|2007
0-19|4.7|5.0|4.8|4118|Incidence|82749431|Other|2007
0-19|0.1|0.2|0.2|140|Mortality|82749431|Soft Tissue|2007
0-19|1.0|1.2|1.1|928|Incidence|82749431|Soft Tissue|2007
0-14|0.2|0.3|0.3|176|Mortality|60907384|Acute Lymphocytic|2008
0-14|3.9|4.2|4.1|2489|Incidence|60907384|Acute Lymphocytic|2008
0-14|0.2|0.2|0.2|127|Mortality|60907384|Acute Myeloid|2008
0-14|0.6|0.8|0.7|436|Incidence|60907384|Acute Myeloid|2008
0-14|2.1|2.3|2.2|1354|Mortality|60907384|All Cancer Sites Combined|2008
0-14|16.2|16.8|16.5|10120|Incidence|60907384|All Cancer Sites Combined|2008
0-14|0.1|0.1|0.1|62|Mortality|60907384|Bones and Joints|2008
0-14|0.6|0.8|0.7|425|Incidence|60907384|Bones and Joints|2008
0-14|0.6|0.8|0.7|429|Mortality|60907384|Brain and Other Nervous System|2008
0-14|3.5|3.8|3.7|2237|Incidence|60907384|Brain and Other Nervous System|2008
0-14|~|~|~|~|Mortality|60907384|Hodgkin Lymphoma|2008
0-14|0.6|0.7|0.6|384|Incidence|60907384|Hodgkin Lymphoma|2008
0-14|0.1|0.1|0.1|46|Mortality|60907384|Kidney and Renal Pelvis|2008
0-14|0.8|1.0|0.9|571|Incidence|60907384|Kidney and Renal Pelvis|2008
0-14|0.6|0.7|0.7|402|Mortality|60907384|Leukemia|2008
0-14|5.0|5.3|5.1|3151|Incidence|60907384|Leukemia|2008
0-14|0.0|0.1|0.1|39|Mortality|60907384|Non-Hodgkin Lymphoma|2008
0-14|0.9|1.0|1.0|582|Incidence|60907384|Non-Hodgkin Lymphoma|2008
0-14|0.4|0.5|0.5|286|Mortality|60907384|Other|2008
0-14|3.3|3.5|3.4|2103|Incidence|60907384|Other|2008
0-14|0.1|0.2|0.1|89|Mortality|60907384|Soft Tissue|2008
0-14|1.0|1.2|1.1|667|Incidence|60907384|Soft Tissue|2008
0-19|0.3|0.3|0.3|253|Mortality|83118264|Acute Lymphocytic|2008
0-19|3.3|3.6|3.5|2861|Incidence|83118264|Acute Lymphocytic|2008
0-19|0.2|0.3|0.2|183|Mortality|83118264|Acute Myeloid|2008
0-19|0.7|0.8|0.7|629|Incidence|83118264|Acute Myeloid|2008
0-19|2.3|2.5|2.4|2039|Mortality|83118264|All Cancer Sites Combined|2008
0-19|17.7|18.2|17.9|15058|Incidence|83118264|All Cancer Sites Combined|2008
0-19|0.2|0.2|0.2|182|Mortality|83118264|Bones and Joints|2008
0-19|0.8|1.0|0.9|750|Incidence|83118264|Bones and Joints|2008
0-19|0.6|0.7|0.6|533|Mortality|83118264|Brain and Other Nervous System|2008
0-19|3.2|3.5|3.3|2764|Incidence|83118264|Brain and Other Nervous System|2008
0-19|~|~|~|~|Mortality|83118264|Hodgkin Lymphoma|2008
0-19|1.2|1.4|1.3|1104|Incidence|83118264|Hodgkin Lymphoma|2008
0-19|0.0|0.1|0.1|52|Mortality|83118264|Kidney and Renal Pelvis|2008
0-19|0.7|0.8|0.7|620|Incidence|83118264|Kidney and Renal Pelvis|2008
0-19|0.7|0.8|0.7|598|Mortality|83118264|Leukemia|2008
0-19|4.5|4.8|4.6|3830|Incidence|83118264|Leukemia|2008
0-19|0.1|0.1|0.1|93|Mortality|83118264|Non-Hodgkin Lymphoma|2008
0-19|1.1|1.2|1.2|964|Incidence|83118264|Non-Hodgkin Lymphoma|2008
0-19|0.4|0.5|0.5|407|Mortality|83118264|Other|2008
0-19|4.7|5.0|4.8|4109|Incidence|83118264|Other|2008
0-19|0.2|0.2|0.2|160|Mortality|83118264|Soft Tissue|2008
0-19|1.0|1.2|1.1|917|Incidence|83118264|Soft Tissue|2008
0-14|0.2|0.3|0.3|174|Mortality|61087581|Acute Lymphocytic|2009
0-14|3.9|4.2|4.1|2511|Incidence|61087581|Acute Lymphocytic|2009
0-14|0.2|0.2|0.2|119|Mortality|61087581|Acute Myeloid|2009
0-14|0.6|0.7|0.6|396|Incidence|61087581|Acute Myeloid|2009
0-14|2.0|2.3|2.2|1320|Mortality|61087581|All Cancer Sites Combined|2009
0-14|16.1|16.7|16.4|10058|Incidence|61087581|All Cancer Sites Combined|2009
0-14|0.1|0.2|0.1|77|Mortality|61087581|Bones and Joints|2009
0-14|0.6|0.8|0.7|433|Incidence|61087581|Bones and Joints|2009
0-14|0.6|0.7|0.7|402|Mortality|61087581|Brain and Other Nervous System|2009
0-14|3.5|3.8|3.6|2231|Incidence|61087581|Brain and Other Nervous System|2009
0-14|~|~|~|~|Mortality|61087581|Hodgkin Lymphoma|2009
0-14|0.5|0.6|0.6|350|Incidence|61087581|Hodgkin Lymphoma|2009
0-14|0.0|0.1|0.1|38|Mortality|61087581|Kidney and Renal Pelvis|2009
0-14|0.9|1.0|1.0|593|Incidence|61087581|Kidney and Renal Pelvis|2009
0-14|0.6|0.7|0.6|389|Mortality|61087581|Leukemia|2009
0-14|4.9|5.3|5.1|3127|Incidence|61087581|Leukemia|2009
0-14|0.0|0.1|0.1|38|Mortality|61087581|Non-Hodgkin Lymphoma|2009
0-14|0.9|1.0|0.9|573|Incidence|61087581|Non-Hodgkin Lymphoma|2009
0-14|0.4|0.5|0.4|271|Mortality|61087581|Other|2009
0-14|3.3|3.6|3.4|2106|Incidence|61087581|Other|2009
0-14|0.1|0.2|0.2|98|Mortality|61087581|Soft Tissue|2009
0-14|1.0|1.1|1.0|645|Incidence|61087581|Soft Tissue|2009
0-19|0.3|0.3|0.3|240|Mortality|83280391|Acute Lymphocytic|2009
0-19|3.3|3.6|3.4|2861|Incidence|83280391|Acute Lymphocytic|2009
0-19|0.2|0.3|0.2|182|Mortality|83280391|Acute Myeloid|2009
0-19|0.6|0.7|0.7|573|Incidence|83280391|Acute Myeloid|2009
0-19|2.2|2.5|2.3|1964|Mortality|83280391|All Cancer Sites Combined|2009
0-19|17.6|18.2|17.9|15015|Incidence|83280391|All Cancer Sites Combined|2009
0-19|0.2|0.2|0.2|179|Mortality|83280391|Bones and Joints|2009
0-19|0.9|1.0|0.9|768|Incidence|83280391|Bones and Joints|2009
0-19|0.6|0.7|0.6|522|Mortality|83280391|Brain and Other Nervous System|2009
0-19|3.2|3.4|3.3|2735|Incidence|83280391|Brain and Other Nervous System|2009
0-19|0.0|0.0|0.0|22|Mortality|83280391|Hodgkin Lymphoma|2009
0-19|1.2|1.3|1.3|1088|Incidence|83280391|Hodgkin Lymphoma|2009
0-19|0.0|0.1|0.1|45|Mortality|83280391|Kidney and Renal Pelvis|2009
0-19|0.7|0.8|0.8|637|Incidence|83280391|Kidney and Renal Pelvis|2009
0-19|0.6|0.7|0.7|561|Mortality|83280391|Leukemia|2009
0-19|4.4|4.7|4.5|3752|Incidence|83280391|Leukemia|2009
0-19|0.1|0.1|0.1|75|Mortality|83280391|Non-Hodgkin Lymphoma|2009
0-19|1.1|1.2|1.1|946|Incidence|83280391|Non-Hodgkin Lymphoma|2009
0-19|0.4|0.5|0.5|396|Mortality|83280391|Other|2009
0-19|4.7|5.0|4.9|4167|Incidence|83280391|Other|2009
0-19|0.2|0.2|0.2|164|Mortality|83280391|Soft Tissue|2009
0-19|1.0|1.2|1.1|922|Incidence|83280391|Soft Tissue|2009
0-14|0.2|0.3|0.3|164|Mortality|61228956|Acute Lymphocytic|2010
0-14|3.9|4.2|4.1|2515|Incidence|61228956|Acute Lymphocytic|2010
0-14|0.2|0.3|0.2|131|Mortality|61228956|Acute Myeloid|2010
0-14|0.6|0.8|0.7|435|Incidence|61228956|Acute Myeloid|2010
0-14|2.0|2.3|2.2|1324|Mortality|61228956|All Cancer Sites Combined|2010
0-14|16.8|17.4|17.1|10513|Incidence|61228956|All Cancer Sites Combined|2010
0-14|0.1|0.2|0.1|75|Mortality|61228956|Bones and Joints|2010
0-14|0.6|0.8|0.7|427|Incidence|61228956|Bones and Joints|2010
0-14|0.6|0.7|0.7|410|Mortality|61228956|Brain and Other Nervous System|2010
0-14|3.6|3.9|3.8|2308|Incidence|61228956|Brain and Other Nervous System|2010
0-14|~|~|~|~|Mortality|61228956|Hodgkin Lymphoma|2010
0-14|0.5|0.6|0.5|323|Incidence|61228956|Hodgkin Lymphoma|2010
0-14|0.1|0.1|0.1|46|Mortality|61228956|Kidney and Renal Pelvis|2010
0-14|0.8|0.9|0.9|539|Incidence|61228956|Kidney and Renal Pelvis|2010
0-14|0.6|0.7|0.6|390|Mortality|61228956|Leukemia|2010
0-14|5.0|5.3|5.1|3163|Incidence|61228956|Leukemia|2010
0-14|0.0|0.1|0.1|35|Mortality|61228956|Non-Hodgkin Lymphoma|2010
0-14|0.9|1.1|1.0|593|Incidence|61228956|Non-Hodgkin Lymphoma|2010
0-14|0.4|0.5|0.5|286|Mortality|61228956|Other|2010
0-14|3.9|4.2|4.1|2498|Incidence|61228956|Other|2010
0-14|0.1|0.2|0.1|79|Mortality|61228956|Soft Tissue|2010
0-14|1.0|1.2|1.1|662|Incidence|61228956|Soft Tissue|2010
0-19|0.2|0.3|0.3|230|Mortality|83225072|Acute Lymphocytic|2010
0-19|3.3|3.6|3.4|2850|Incidence|83225072|Acute Lymphocytic|2010
0-19|0.2|0.3|0.2|198|Mortality|83225072|Acute Myeloid|2010
0-19|0.7|0.8|0.8|636|Incidence|83225072|Acute Myeloid|2010
0-19|2.2|2.4|2.3|1925|Mortality|83225072|All Cancer Sites Combined|2010
0-19|18.0|18.6|18.3|15320|Incidence|83225072|All Cancer Sites Combined|2010
0-19|0.2|0.2|0.2|166|Mortality|83225072|Bones and Joints|2010
0-19|0.8|0.9|0.9|719|Incidence|83225072|Bones and Joints|2010
0-19|0.6|0.7|0.6|498|Mortality|83225072|Brain and Other Nervous System|2010
0-19|3.2|3.5|3.4|2786|Incidence|83225072|Brain and Other Nervous System|2010
0-19|~|~|~|~|Mortality|83225072|Hodgkin Lymphoma|2010
0-19|1.1|1.3|1.2|1037|Incidence|83225072|Hodgkin Lymphoma|2010
0-19|0.1|0.1|0.1|56|Mortality|83225072|Kidney and Renal Pelvis|2010
0-19|0.6|0.7|0.7|573|Incidence|83225072|Kidney and Renal Pelvis|2010
0-19|0.6|0.7|0.7|553|Mortality|83225072|Leukemia|2010
0-19|4.4|4.7|4.6|3807|Incidence|83225072|Leukemia|2010
0-19|0.1|0.1|0.1|75|Mortality|83225072|Non-Hodgkin Lymphoma|2010
0-19|1.1|1.2|1.1|951|Incidence|83225072|Non-Hodgkin Lymphoma|2010
0-19|0.5|0.6|0.5|419|Mortality|83225072|Other|2010
0-19|5.2|5.5|5.4|4536|Incidence|83225072|Other|2010
0-19|0.1|0.2|0.2|146|Mortality|83225072|Soft Tissue|2010
0-19|1.0|1.2|1.1|911|Incidence|83225072|Soft Tissue|2010
0-14|0.2|0.3|0.2|153|Mortality|61310580|Acute Lymphocytic|2011
0-14|4.0|4.3|4.2|2570|Incidence|61310580|Acute Lymphocytic|2011
0-14|0.2|0.2|0.2|117|Mortality|61310580|Acute Myeloid|2011
0-14|0.6|0.8|0.7|429|Incidence|61310580|Acute Myeloid|2011
0-14|2.0|2.2|2.1|1283|Mortality|61310580|All Cancer Sites Combined|2011
0-14|16.7|17.4|17.1|10503|Incidence|61310580|All Cancer Sites Combined|2011
0-14|0.1|0.2|0.1|73|Mortality|61310580|Bones and Joints|2011
0-14|0.7|0.8|0.8|464|Incidence|61310580|Bones and Joints|2011
0-14|0.7|0.8|0.7|439|Mortality|61310580|Brain and Other Nervous System|2011
0-14|3.6|3.9|3.7|2279|Incidence|61310580|Brain and Other Nervous System|2011
0-14|~|~|~|~|Mortality|61310580|Hodgkin Lymphoma|2011
0-14|0.5|0.6|0.5|319|Incidence|61310580|Hodgkin Lymphoma|2011
0-14|0.0|0.1|0.1|39|Mortality|61310580|Kidney and Renal Pelvis|2011
0-14|0.9|1.0|0.9|574|Incidence|61310580|Kidney and Renal Pelvis|2011
0-14|0.5|0.6|0.6|342|Mortality|61310580|Leukemia|2011
0-14|5.0|5.4|5.2|3207|Incidence|61310580|Leukemia|2011
0-14|0.0|0.1|0.1|32|Mortality|61310580|Non-Hodgkin Lymphoma|2011
0-14|0.8|1.0|0.9|563|Incidence|61310580|Non-Hodgkin Lymphoma|2011
0-14|0.4|0.5|0.4|273|Mortality|61310580|Other|2011
0-14|3.9|4.2|4.0|2479|Incidence|61310580|Other|2011
0-14|0.1|0.2|0.1|84|Mortality|61310580|Soft Tissue|2011
0-14|0.9|1.1|1.0|618|Incidence|61310580|Soft Tissue|2011
0-19|0.2|0.3|0.3|223|Mortality|83042807|Acute Lymphocytic|2011
0-19|3.4|3.7|3.6|2944|Incidence|83042807|Acute Lymphocytic|2011
0-19|0.2|0.2|0.2|174|Mortality|83042807|Acute Myeloid|2011
0-19|0.7|0.8|0.8|636|Incidence|83042807|Acute Myeloid|2011
0-19|2.2|2.4|2.3|1922|Mortality|83042807|All Cancer Sites Combined|2011
0-19|18.2|18.8|18.5|15414|Incidence|83042807|All Cancer Sites Combined|2011
0-19|0.2|0.2|0.2|174|Mortality|83042807|Bones and Joints|2011
0-19|0.8|1.0|0.9|760|Incidence|83042807|Bones and Joints|2011
0-19|0.6|0.7|0.7|550|Mortality|83042807|Brain and Other Nervous System|2011
0-19|3.3|3.6|3.4|2843|Incidence|83042807|Brain and Other Nervous System|2011
0-19|0.0|0.0|0.0|17|Mortality|83042807|Hodgkin Lymphoma|2011
0-19|1.1|1.3|1.2|1008|Incidence|83042807|Hodgkin Lymphoma|2011
0-19|0.0|0.1|0.1|45|Mortality|83042807|Kidney and Renal Pelvis|2011
0-19|0.7|0.8|0.7|618|Incidence|83042807|Kidney and Renal Pelvis|2011
0-19|0.6|0.7|0.6|519|Mortality|83042807|Leukemia|2011
0-19|4.5|4.8|4.7|3887|Incidence|83042807|Leukemia|2011
0-19|0.1|0.1|0.1|64|Mortality|83042807|Non-Hodgkin Lymphoma|2011
0-19|1.1|1.2|1.1|939|Incidence|83042807|Non-Hodgkin Lymphoma|2011
0-19|0.4|0.5|0.5|405|Mortality|83042807|Other|2011
0-19|5.2|5.5|5.4|4510|Incidence|83042807|Other|2011
0-19|0.1|0.2|0.2|148|Mortality|83042807|Soft Tissue|2011
0-19|1.0|1.1|1.0|849|Incidence|83042807|Soft Tissue|2011
0-14|0.2|0.3|0.2|152|Mortality|61369720|Acute Lymphocytic|2012
0-14|3.8|4.1|4.0|2459|Incidence|61369720|Acute Lymphocytic|2012
0-14|0.2|0.3|0.2|137|Mortality|61369720|Acute Myeloid|2012
0-14|0.6|0.7|0.6|395|Incidence|61369720|Acute Myeloid|2012
0-14|2.1|2.3|2.2|1367|Mortality|61369720|All Cancer Sites Combined|2012
0-14|16.6|17.3|17.0|10439|Incidence|61369720|All Cancer Sites Combined|2012
0-14|0.1|0.1|0.1|68|Mortality|61369720|Bones and Joints|2012
0-14|0.7|0.8|0.8|462|Incidence|61369720|Bones and Joints|2012
0-14|0.7|0.8|0.7|458|Mortality|61369720|Brain and Other Nervous System|2012
0-14|3.5|3.8|3.7|2251|Incidence|61369720|Brain and Other Nervous System|2012
0-14|~|~|~|~|Mortality|61369720|Hodgkin Lymphoma|2012
0-14|0.5|0.6|0.6|350|Incidence|61369720|Hodgkin Lymphoma|2012
0-14|0.0|0.1|0.0|30|Mortality|61369720|Kidney and Renal Pelvis|2012
0-14|0.8|1.0|0.9|544|Incidence|61369720|Kidney and Renal Pelvis|2012
0-14|0.6|0.7|0.6|378|Mortality|61369720|Leukemia|2012
0-14|4.8|5.1|4.9|3050|Incidence|61369720|Leukemia|2012
0-14|0.0|0.1|0.1|36|Mortality|61369720|Non-Hodgkin Lymphoma|2012
0-14|0.9|1.1|1.0|619|Incidence|61369720|Non-Hodgkin Lymphoma|2012
0-14|0.4|0.5|0.5|292|Mortality|61369720|Other|2012
0-14|3.9|4.3|4.1|2517|Incidence|61369720|Other|2012
0-14|0.1|0.2|0.2|101|Mortality|61369720|Soft Tissue|2012
0-14|1.0|1.1|1.1|646|Incidence|61369720|Soft Tissue|2012
0-19|0.2|0.3|0.3|219|Mortality|82869473|Acute Lymphocytic|2012
0-19|3.3|3.5|3.4|2792|Incidence|82869473|Acute Lymphocytic|2012
0-19|0.2|0.3|0.2|193|Mortality|82869473|Acute Myeloid|2012
0-19|0.7|0.8|0.7|594|Incidence|82869473|Acute Myeloid|2012
0-19|2.3|2.5|2.4|1995|Mortality|82869473|All Cancer Sites Combined|2012
0-19|18.3|18.9|18.6|15444|Incidence|82869473|All Cancer Sites Combined|2012
0-19|0.2|0.2|0.2|178|Mortality|82869473|Bones and Joints|2012
0-19|0.9|1.0|0.9|776|Incidence|82869473|Bones and Joints|2012
0-19|0.6|0.8|0.7|575|Mortality|82869473|Brain and Other Nervous System|2012
0-19|3.2|3.5|3.3|2762|Incidence|82869473|Brain and Other Nervous System|2012
0-19|~|~|~|~|Mortality|82869473|Hodgkin Lymphoma|2012
0-19|1.2|1.3|1.2|1049|Incidence|82869473|Hodgkin Lymphoma|2012
0-19|0.0|0.1|0.0|40|Mortality|82869473|Kidney and Renal Pelvis|2012
0-19|0.7|0.8|0.7|597|Incidence|82869473|Kidney and Renal Pelvis|2012
0-19|0.6|0.7|0.6|534|Mortality|82869473|Leukemia|2012
0-19|4.3|4.6|4.5|3694|Incidence|82869473|Leukemia|2012
0-19|0.1|0.1|0.1|60|Mortality|82869473|Non-Hodgkin Lymphoma|2012
0-19|1.2|1.3|1.2|1041|Incidence|82869473|Non-Hodgkin Lymphoma|2012
0-19|0.5|0.6|0.5|421|Mortality|82869473|Other|2012
0-19|5.4|5.7|5.6|4670|Incidence|82869473|Other|2012
0-19|0.2|0.2|0.2|177|Mortality|82869473|Soft Tissue|2012
0-19|1.0|1.1|1.0|855|Incidence|82869473|Soft Tissue|2012
0-14|0.2|0.3|0.2|141|Mortality|61438344|Acute Lymphocytic|2013
0-14|3.6|3.9|3.8|2320|Incidence|61438344|Acute Lymphocytic|2013
0-14|0.2|0.2|0.2|127|Mortality|61438344|Acute Myeloid|2013
0-14|0.7|0.8|0.7|440|Incidence|61438344|Acute Myeloid|2013
0-14|2.0|2.2|2.1|1287|Mortality|61438344|All Cancer Sites Combined|2013
0-14|16.9|17.6|17.2|10589|Incidence|61438344|All Cancer Sites Combined|2013
0-14|0.1|0.1|0.1|72|Mortality|61438344|Bones and Joints|2013
0-14|0.7|0.8|0.8|474|Incidence|61438344|Bones and Joints|2013
0-14|0.6|0.8|0.7|437|Mortality|61438344|Brain and Other Nervous System|2013
0-14|3.6|3.9|3.8|2331|Incidence|61438344|Brain and Other Nervous System|2013
0-14|~|~|~|~|Mortality|61438344|Hodgkin Lymphoma|2013
0-14|0.5|0.6|0.6|340|Incidence|61438344|Hodgkin Lymphoma|2013
0-14|0.0|0.1|0.1|40|Mortality|61438344|Kidney and Renal Pelvis|2013
0-14|0.8|1.0|0.9|559|Incidence|61438344|Kidney and Renal Pelvis|2013
0-14|0.5|0.6|0.6|350|Mortality|61438344|Leukemia|2013
0-14|4.7|5.0|4.9|2996|Incidence|61438344|Leukemia|2013
0-14|0.0|0.1|0.0|29|Mortality|61438344|Non-Hodgkin Lymphoma|2013
0-14|0.9|1.1|1.0|601|Incidence|61438344|Non-Hodgkin Lymphoma|2013
0-14|0.4|0.5|0.4|254|Mortality|61438344|Other|2013
0-14|4.1|4.4|4.3|2623|Incidence|61438344|Other|2013
0-14|0.1|0.2|0.2|101|Mortality|61438344|Soft Tissue|2013
0-14|1.0|1.2|1.1|665|Incidence|61438344|Soft Tissue|2013
0-19|0.2|0.3|0.2|197|Mortality|82802400|Acute Lymphocytic|2013
0-19|3.1|3.3|3.2|2655|Incidence|82802400|Acute Lymphocytic|2013
0-19|0.2|0.3|0.2|186|Mortality|82802400|Acute Myeloid|2013
0-19|0.7|0.8|0.8|633|Incidence|82802400|Acute Myeloid|2013
0-19|2.2|2.4|2.3|1914|Mortality|82802400|All Cancer Sites Combined|2013
0-19|18.2|18.8|18.5|15326|Incidence|82802400|All Cancer Sites Combined|2013
0-19|0.2|0.2|0.2|180|Mortality|82802400|Bones and Joints|2013
0-19|0.9|1.0|0.9|789|Incidence|82802400|Bones and Joints|2013
0-19|0.6|0.7|0.7|556|Mortality|82802400|Brain and Other Nervous System|2013
0-19|3.3|3.6|3.4|2833|Incidence|82802400|Brain and Other Nervous System|2013
0-19|~|~|~|~|Mortality|82802400|Hodgkin Lymphoma|2013
0-19|1.1|1.2|1.2|967|Incidence|82802400|Hodgkin Lymphoma|2013
0-19|0.0|0.1|0.1|46|Mortality|82802400|Kidney and Renal Pelvis|2013
0-19|0.7|0.8|0.7|616|Incidence|82802400|Kidney and Renal Pelvis|2013
0-19|0.6|0.7|0.6|509|Mortality|82802400|Leukemia|2013
0-19|4.3|4.6|4.4|3643|Incidence|82802400|Leukemia|2013
0-19|0.1|0.1|0.1|60|Mortality|82802400|Non-Hodgkin Lymphoma|2013
0-19|1.1|1.2|1.2|970|Incidence|82802400|Non-Hodgkin Lymphoma|2013
0-19|0.4|0.5|0.4|367|Mortality|82802400|Other|2013
0-19|5.4|5.7|5.6|4624|Incidence|82802400|Other|2013
0-19|0.2|0.3|0.2|183|Mortality|82802400|Soft Tissue|2013
0-19|1.0|1.1|1.1|884|Incidence|82802400|Soft Tissue|2013
0-14|0.2|0.3|0.2|141|Mortality|61538034|Acute Lymphocytic|2014
0-14|3.7|4.0|3.9|2373|Incidence|61538034|Acute Lymphocytic|2014
0-14|0.1|0.2|0.2|94|Mortality|61538034|Acute Myeloid|2014
0-14|0.7|0.8|0.7|447|Incidence|61538034|Acute Myeloid|2014
0-14|1.9|2.1|2.0|1225|Mortality|61538034|All Cancer Sites Combined|2014
0-14|17.2|17.9|17.6|10817|Incidence|61538034|All Cancer Sites Combined|2014
0-14|0.1|0.2|0.1|85|Mortality|61538034|Bones and Joints|2014
0-14|0.7|0.9|0.8|494|Incidence|61538034|Bones and Joints|2014
0-14|0.6|0.8|0.7|420|Mortality|61538034|Brain and Other Nervous System|2014
0-14|3.6|3.9|3.8|2330|Incidence|61538034|Brain and Other Nervous System|2014
0-14|~|~|~|~|Mortality|61538034|Hodgkin Lymphoma|2014
0-14|0.5|0.6|0.5|337|Incidence|61538034|Hodgkin Lymphoma|2014
0-14|0.0|0.1|0.0|24|Mortality|61538034|Kidney and Renal Pelvis|2014
0-14|0.9|1.0|0.9|577|Incidence|61538034|Kidney and Renal Pelvis|2014
0-14|0.4|0.5|0.5|296|Mortality|61538034|Leukemia|2014
0-14|4.8|5.1|5.0|3050|Incidence|61538034|Leukemia|2014
0-14|0.0|0.1|0.1|39|Mortality|61538034|Non-Hodgkin Lymphoma|2014
0-14|1.0|1.2|1.1|695|Incidence|61538034|Non-Hodgkin Lymphoma|2014
0-14|0.4|0.5|0.5|285|Mortality|61538034|Other|2014
0-14|4.2|4.5|4.3|2676|Incidence|61538034|Other|2014
0-14|0.1|0.2|0.1|76|Mortality|61538034|Soft Tissue|2014
0-14|1.0|1.2|1.1|658|Incidence|61538034|Soft Tissue|2014
0-19|0.2|0.3|0.2|207|Mortality|82834118|Acute Lymphocytic|2014
0-19|3.2|3.4|3.3|2728|Incidence|82834118|Acute Lymphocytic|2014
0-19|0.2|0.2|0.2|148|Mortality|82834118|Acute Myeloid|2014
0-19|0.7|0.9|0.8|660|Incidence|82834118|Acute Myeloid|2014
0-19|2.1|2.3|2.2|1837|Mortality|82834118|All Cancer Sites Combined|2014
0-19|18.7|19.3|19.0|15810|Incidence|82834118|All Cancer Sites Combined|2014
0-19|0.2|0.3|0.2|181|Mortality|82834118|Bones and Joints|2014
0-19|0.9|1.0|1.0|794|Incidence|82834118|Bones and Joints|2014
0-19|0.6|0.7|0.7|559|Mortality|82834118|Brain and Other Nervous System|2014
0-19|3.3|3.6|3.4|2845|Incidence|82834118|Brain and Other Nervous System|2014
0-19|~|~|~|~|Mortality|82834118|Hodgkin Lymphoma|2014
0-19|1.1|1.3|1.2|992|Incidence|82834118|Hodgkin Lymphoma|2014
0-19|0.0|0.1|0.0|34|Mortality|82834118|Kidney and Renal Pelvis|2014
0-19|0.7|0.8|0.8|627|Incidence|82834118|Kidney and Renal Pelvis|2014
0-19|0.5|0.6|0.5|456|Mortality|82834118|Leukemia|2014
0-19|4.4|4.7|4.5|3740|Incidence|82834118|Leukemia|2014
0-19|0.1|0.1|0.1|69|Mortality|82834118|Non-Hodgkin Lymphoma|2014
0-19|1.3|1.5|1.4|1142|Incidence|82834118|Non-Hodgkin Lymphoma|2014
0-19|0.4|0.5|0.5|389|Mortality|82834118|Other|2014
0-19|5.6|5.9|5.7|4770|Incidence|82834118|Other|2014
0-19|0.1|0.2|0.2|143|Mortality|82834118|Soft Tissue|2014
0-19|1.0|1.2|1.1|900|Incidence|82834118|Soft Tissue|2014
0-14|0.2|0.3|0.2|146|Mortality|61598538|Acute Lymphocytic|2015
0-14|3.9|4.3|4.1|2526|Incidence|61598538|Acute Lymphocytic|2015
0-14|0.2|0.2|0.2|119|Mortality|61598538|Acute Myeloid|2015
0-14|0.7|0.8|0.7|449|Incidence|61598538|Acute Myeloid|2015
0-14|2.0|2.2|2.1|1272|Mortality|61598538|All Cancer Sites Combined|2015
0-14|17.5|18.2|17.8|11007|Incidence|61598538|All Cancer Sites Combined|2015
0-14|0.1|0.2|0.1|84|Mortality|61598538|Bones and Joints|2015
0-14|0.7|0.9|0.8|481|Incidence|61598538|Bones and Joints|2015
0-14|0.6|0.8|0.7|430|Mortality|61598538|Brain and Other Nervous System|2015
0-14|3.5|3.8|3.7|2254|Incidence|61598538|Brain and Other Nervous System|2015
0-14|~|~|~|~|Mortality|61598538|Hodgkin Lymphoma|2015
0-14|0.5|0.6|0.6|360|Incidence|61598538|Hodgkin Lymphoma|2015
0-14|0.0|0.1|0.1|36|Mortality|61598538|Kidney and Renal Pelvis|2015
0-14|0.9|1.1|1.0|610|Incidence|61598538|Kidney and Renal Pelvis|2015
0-14|0.5|0.6|0.6|343|Mortality|61598538|Leukemia|2015
0-14|5.0|5.4|5.2|3193|Incidence|61598538|Leukemia|2015
0-14|0.0|0.1|0.1|35|Mortality|61598538|Non-Hodgkin Lymphoma|2015
0-14|0.9|1.1|1.0|629|Incidence|61598538|Non-Hodgkin Lymphoma|2015
0-14|0.3|0.4|0.4|235|Mortality|61598538|Other|2015
0-14|4.4|4.7|4.6|2816|Incidence|61598538|Other|2015
0-14|0.1|0.2|0.2|105|Mortality|61598538|Soft Tissue|2015
0-14|1.0|1.2|1.1|664|Incidence|61598538|Soft Tissue|2015
0-19|0.2|0.3|0.2|206|Mortality|82981714|Acute Lymphocytic|2015
0-19|3.4|3.7|3.5|2921|Incidence|82981714|Acute Lymphocytic|2015
0-19|0.2|0.2|0.2|175|Mortality|82981714|Acute Myeloid|2015
0-19|0.7|0.8|0.8|638|Incidence|82981714|Acute Myeloid|2015
0-19|2.1|2.3|2.2|1855|Mortality|82981714|All Cancer Sites Combined|2015
0-19|19.3|19.9|19.6|16292|Incidence|82981714|All Cancer Sites Combined|2015
0-19|0.2|0.3|0.2|197|Mortality|82981714|Bones and Joints|2015
0-19|0.9|1.0|0.9|786|Incidence|82981714|Bones and Joints|2015
0-19|0.6|0.7|0.6|531|Mortality|82981714|Brain and Other Nervous System|2015
0-19|3.2|3.5|3.3|2772|Incidence|82981714|Brain and Other Nervous System|2015
0-19|~|~|~|~|Mortality|82981714|Hodgkin Lymphoma|2015
0-19|1.2|1.3|1.2|1030|Incidence|82981714|Hodgkin Lymphoma|2015
0-19|0.0|0.1|0.1|44|Mortality|82981714|Kidney and Renal Pelvis|2015
0-19|0.7|0.9|0.8|663|Incidence|82981714|Kidney and Renal Pelvis|2015
0-19|0.5|0.6|0.6|490|Mortality|82981714|Leukemia|2015
0-19|4.6|4.9|4.7|3895|Incidence|82981714|Leukemia|2015
0-19|0.1|0.1|0.1|73|Mortality|82981714|Non-Hodgkin Lymphoma|2015
0-19|1.2|1.3|1.3|1057|Incidence|82981714|Non-Hodgkin Lymphoma|2015
0-19|0.4|0.5|0.4|350|Mortality|82981714|Other|2015
0-19|6.0|6.3|6.2|5156|Incidence|82981714|Other|2015
0-19|0.2|0.2|0.2|158|Mortality|82981714|Soft Tissue|2015
0-19|1.1|1.2|1.1|933|Incidence|82981714|Soft Tissue|2015
0-14|0.2|0.3|0.2|146|Mortality|61701909|Acute Lymphocytic|2016
0-14|4.0|4.3|4.1|2546|Incidence|61701909|Acute Lymphocytic|2016
0-14|0.2|0.3|0.2|133|Mortality|61701909|Acute Myeloid|2016
0-14|0.7|0.8|0.8|466|Incidence|61701909|Acute Myeloid|2016
0-14|2.0|2.3|2.1|1324|Mortality|61701909|All Cancer Sites Combined|2016
0-14|17.3|18.0|17.7|10916|Incidence|61701909|All Cancer Sites Combined|2016
0-14|0.1|0.2|0.1|82|Mortality|61701909|Bones and Joints|2016
0-14|0.8|0.9|0.8|510|Incidence|61701909|Bones and Joints|2016
0-14|0.7|0.8|0.7|444|Mortality|61701909|Brain and Other Nervous System|2016
0-14|3.6|3.9|3.7|2287|Incidence|61701909|Brain and Other Nervous System|2016
0-14|~|~|~|~|Mortality|61701909|Hodgkin Lymphoma|2016
0-14|0.5|0.6|0.6|352|Incidence|61701909|Hodgkin Lymphoma|2016
0-14|0.0|0.1|0.1|38|Mortality|61701909|Kidney and Renal Pelvis|2016
0-14|0.8|1.0|0.9|540|Incidence|61701909|Kidney and Renal Pelvis|2016
0-14|0.5|0.6|0.6|351|Mortality|61701909|Leukemia|2016
0-14|5.1|5.4|5.2|3232|Incidence|61701909|Leukemia|2016
0-14|0.0|0.1|0.1|31|Mortality|61701909|Non-Hodgkin Lymphoma|2016
0-14|1.0|1.2|1.1|668|Incidence|61701909|Non-Hodgkin Lymphoma|2016
0-14|0.4|0.5|0.4|269|Mortality|61701909|Other|2016
0-14|4.2|4.5|4.3|2682|Incidence|61701909|Other|2016
0-14|0.1|0.2|0.2|107|Mortality|61701909|Soft Tissue|2016
0-14|1.0|1.1|1.0|645|Incidence|61701909|Soft Tissue|2016
0-19|0.2|0.3|0.3|218|Mortality|83193069|Acute Lymphocytic|2016
0-19|3.4|3.7|3.5|2932|Incidence|83193069|Acute Lymphocytic|2016
0-19|0.2|0.2|0.2|179|Mortality|83193069|Acute Myeloid|2016
0-19|0.7|0.9|0.8|662|Incidence|83193069|Acute Myeloid|2016
0-19|2.2|2.4|2.3|1920|Mortality|83193069|All Cancer Sites Combined|2016
0-19|19.1|19.7|19.4|16181|Incidence|83193069|All Cancer Sites Combined|2016
0-19|0.2|0.3|0.2|200|Mortality|83193069|Bones and Joints|2016
0-19|0.9|1.1|1.0|838|Incidence|83193069|Bones and Joints|2016
0-19|0.6|0.7|0.7|552|Mortality|83193069|Brain and Other Nervous System|2016
0-19|3.2|3.4|3.3|2743|Incidence|83193069|Brain and Other Nervous System|2016
0-19|~|~|~|~|Mortality|83193069|Hodgkin Lymphoma|2016
0-19|1.2|1.3|1.2|1044|Incidence|83193069|Hodgkin Lymphoma|2016
0-19|0.0|0.1|0.1|51|Mortality|83193069|Kidney and Renal Pelvis|2016
0-19|0.7|0.8|0.7|585|Incidence|83193069|Kidney and Renal Pelvis|2016
0-19|0.5|0.7|0.6|499|Mortality|83193069|Leukemia|2016
0-19|4.6|4.9|4.7|3919|Incidence|83193069|Leukemia|2016
0-19|0.1|0.1|0.1|60|Mortality|83193069|Non-Hodgkin Lymphoma|2016
0-19|1.2|1.4|1.3|1089|Incidence|83193069|Non-Hodgkin Lymphoma|2016
0-19|0.4|0.5|0.5|385|Mortality|83193069|Other|2016
0-19|5.9|6.2|6.0|5057|Incidence|83193069|Other|2016
0-19|0.2|0.2|0.2|167|Mortality|83193069|Soft Tissue|2016
0-19|1.0|1.2|1.1|906|Incidence|83193069|Soft Tissue|2016
0-14|0.2|0.2|0.2|122|Mortality|61805607|Acute Lymphocytic|2017
0-14|3.8|4.1|3.9|2425|Incidence|61805607|Acute Lymphocytic|2017
0-14|0.2|0.2|0.2|128|Mortality|61805607|Acute Myeloid|2017
0-14|0.6|0.8|0.7|434|Incidence|61805607|Acute Myeloid|2017
0-14|1.9|2.1|2.0|1237|Mortality|61805607|All Cancer Sites Combined|2017
0-14|17.0|17.6|17.3|10702|Incidence|61805607|All Cancer Sites Combined|2017
0-14|0.1|0.1|0.1|67|Mortality|61805607|Bones and Joints|2017
0-14|0.7|0.8|0.8|476|Incidence|61805607|Bones and Joints|2017
0-14|0.6|0.8|0.7|422|Mortality|61805607|Brain and Other Nervous System|2017
0-14|3.7|4.0|3.9|2385|Incidence|61805607|Brain and Other Nervous System|2017
0-14|~|~|~|~|Mortality|61805607|Hodgkin Lymphoma|2017
0-14|0.5|0.6|0.6|355|Incidence|61805607|Hodgkin Lymphoma|2017
0-14|0.0|0.1|0.1|38|Mortality|61805607|Kidney and Renal Pelvis|2017
0-14|0.8|1.0|0.9|541|Incidence|61805607|Kidney and Renal Pelvis|2017
0-14|0.5|0.6|0.5|315|Mortality|61805607|Leukemia|2017
0-14|4.8|5.1|5.0|3071|Incidence|61805607|Leukemia|2017
0-14|0.0|0.1|0.1|34|Mortality|61805607|Non-Hodgkin Lymphoma|2017
0-14|0.9|1.1|1.0|618|Incidence|61805607|Non-Hodgkin Lymphoma|2017
0-14|0.4|0.5|0.4|258|Mortality|61805607|Other|2017
0-14|4.1|4.4|4.2|2625|Incidence|61805607|Other|2017
0-14|0.1|0.2|0.2|102|Mortality|61805607|Soft Tissue|2017
0-14|0.9|1.1|1.0|631|Incidence|61805607|Soft Tissue|2017
0-19|0.2|0.3|0.2|181|Mortality|83318260|Acute Lymphocytic|2017
0-19|3.2|3.5|3.3|2778|Incidence|83318260|Acute Lymphocytic|2017
0-19|0.2|0.3|0.2|187|Mortality|83318260|Acute Myeloid|2017
0-19|0.7|0.8|0.7|610|Incidence|83318260|Acute Myeloid|2017
0-19|2.1|2.3|2.2|1797|Mortality|83318260|All Cancer Sites Combined|2017
0-19|18.6|19.2|18.9|15793|Incidence|83318260|All Cancer Sites Combined|2017
0-19|0.2|0.2|0.2|171|Mortality|83318260|Bones and Joints|2017
0-19|0.9|1.0|1.0|806|Incidence|83318260|Bones and Joints|2017
0-19|0.6|0.7|0.6|519|Mortality|83318260|Brain and Other Nervous System|2017
0-19|3.4|3.7|3.5|2930|Incidence|83318260|Brain and Other Nervous System|2017
0-19|~|~|~|~|Mortality|83318260|Hodgkin Lymphoma|2017
0-19|1.1|1.3|1.2|1018|Incidence|83318260|Hodgkin Lymphoma|2017
0-19|0.0|0.1|0.1|47|Mortality|83318260|Kidney and Renal Pelvis|2017
0-19|0.7|0.8|0.7|584|Incidence|83318260|Kidney and Renal Pelvis|2017
0-19|0.5|0.6|0.6|460|Mortality|83318260|Leukemia|2017
0-19|4.3|4.6|4.5|3715|Incidence|83318260|Leukemia|2017
0-19|0.1|0.1|0.1|58|Mortality|83318260|Non-Hodgkin Lymphoma|2017
0-19|1.2|1.3|1.2|1031|Incidence|83318260|Non-Hodgkin Lymphoma|2017
0-19|0.4|0.5|0.4|368|Mortality|83318260|Other|2017
0-19|5.6|5.9|5.7|4802|Incidence|83318260|Other|2017
0-19|0.2|0.2|0.2|164|Mortality|83318260|Soft Tissue|2017
0-19|1.0|1.2|1.1|907|Incidence|83318260|Soft Tissue|2017
0-14|4.0|4.3|4.1|2546|Incidence|61793399|Acute Lymphocytic|2018
0-14|0.6|0.8|0.7|435|Incidence|61793399|Acute Myeloid|2018
0-14|17.0|17.7|17.4|10726|Incidence|61793399|All Cancer Sites Combined|2018
0-14|0.7|0.9|0.8|510|Incidence|61793399|Bones and Joints|2018
0-14|3.3|3.6|3.4|2127|Incidence|61793399|Brain and Other Nervous System|2018
0-14|0.5|0.7|0.6|369|Incidence|61793399|Hodgkin Lymphoma|2018
0-14|0.8|1.0|0.9|538|Incidence|61793399|Kidney and Renal Pelvis|2018
0-14|5.0|5.4|5.2|3209|Incidence|61793399|Leukemia|2018
0-14|1.0|1.1|1.0|641|Incidence|61793399|Non-Hodgkin Lymphoma|2018
0-14|4.2|4.6|4.4|2720|Incidence|61793399|Other|2018
0-14|0.9|1.1|1.0|612|Incidence|61793399|Soft Tissue|2018
0-19|3.5|3.7|3.6|2979|Incidence|83333434|Acute Lymphocytic|2018
0-19|0.7|0.8|0.7|610|Incidence|83333434|Acute Myeloid|2018
0-19|18.8|19.4|19.1|15949|Incidence|83333434|All Cancer Sites Combined|2018
0-19|0.9|1.1|1.0|841|Incidence|83333434|Bones and Joints|2018
0-19|3.0|3.3|3.1|2612|Incidence|83333434|Brain and Other Nervous System|2018
0-19|1.2|1.3|1.2|1042|Incidence|83333434|Hodgkin Lymphoma|2018
0-19|0.7|0.8|0.7|583|Incidence|83333434|Kidney and Renal Pelvis|2018
0-19|4.6|4.9|4.7|3930|Incidence|83333434|Leukemia|2018
0-19|1.1|1.3|1.2|1025|Incidence|83333434|Non-Hodgkin Lymphoma|2018
0-19|5.9|6.2|6.0|5072|Incidence|83333434|Other|2018
0-19|0.9|1.1|1.0|844|Incidence|83333434|Soft Tissue|2018
0-14|3.8|4.1|3.9|2412|Incidence|61640530|Acute Lymphocytic|2019
0-14|0.7|0.8|0.7|451|Incidence|61640530|Acute Myeloid|2019
0-14|16.5|17.2|16.8|10367|Incidence|61640530|All Cancer Sites Combined|2019
0-14|0.7|0.9|0.8|501|Incidence|61640530|Bones and Joints|2019
0-14|3.2|3.5|3.3|2039|Incidence|61640530|Brain and Other Nervous System|2019
0-14|0.5|0.6|0.6|347|Incidence|61640530|Hodgkin Lymphoma|2019
0-14|0.8|0.9|0.8|502|Incidence|61640530|Kidney and Renal Pelvis|2019
0-14|4.8|5.1|5.0|3048|Incidence|61640530|Leukemia|2019
0-14|0.9|1.0|1.0|593|Incidence|61640530|Non-Hodgkin Lymphoma|2019
0-14|4.2|4.5|4.3|2657|Incidence|61640530|Other|2019
0-14|1.0|1.2|1.1|680|Incidence|61640530|Soft Tissue|2019
0-19|3.3|3.5|3.4|2803|Incidence|83226688|Acute Lymphocytic|2019
0-19|0.7|0.8|0.8|630|Incidence|83226688|Acute Myeloid|2019
0-19|18.5|19.1|18.8|15649|Incidence|83226688|All Cancer Sites Combined|2019
0-19|0.9|1.0|1.0|806|Incidence|83226688|Bones and Joints|2019
0-19|2.9|3.2|3.0|2522|Incidence|83226688|Brain and Other Nervous System|2019
0-19|1.2|1.3|1.2|1056|Incidence|83226688|Hodgkin Lymphoma|2019
0-19|0.6|0.7|0.7|555|Incidence|83226688|Kidney and Renal Pelvis|2019
0-19|4.4|4.6|4.5|3722|Incidence|83226688|Leukemia|2019
0-19|1.1|1.3|1.2|999|Incidence|83226688|Non-Hodgkin Lymphoma|2019
0-19|5.8|6.2|6.0|5026|Incidence|83226688|Other|2019
0-19|1.1|1.2|1.2|963|Incidence|83226688|Soft Tissue|2019
0-14|4.0|4.1|4.0|12213|Incidence|303685675|Acute Lymphocytic|2019-2023
0-14|0.7|0.7|0.7|2151|Incidence|303685675|Acute Myeloid|2019-2023
0-14|16.3|16.6|16.4|49726|Incidence|303685675|All Cancer Sites Combined|2019-2023
0-14|0.7|0.8|0.8|2348|Incidence|303685675|Bones and Joints|2019-2023
0-14|3.1|3.2|3.1|9430|Incidence|303685675|Brain and Other Nervous System|2019-2023
0-14|0.5|0.6|0.6|1746|Incidence|303685675|Hodgkin Lymphoma|2019-2023
0-14|0.9|0.9|0.9|2639|Incidence|303685675|Kidney and Renal Pelvis|2019-2023
0-14|5.0|5.1|5.0|15216|Incidence|303685675|Leukemia|2019-2023
0-14|1.0|1.1|1.1|3312|Incidence|303685675|Non-Hodgkin Lymphoma|2019-2023
0-14|3.9|4.0|3.9|11887|Incidence|303685675|Other|2019-2023
0-14|1.0|1.1|1.0|3148|Incidence|303685675|Soft Tissue|2019-2023
0-19|3.4|3.6|3.5|14257|Incidence|412527765|Acute Lymphocytic|2019-2023
0-19|0.7|0.8|0.8|3129|Incidence|412527765|Acute Myeloid|2019-2023
0-19|18.2|18.5|18.4|75995|Incidence|412527765|All Cancer Sites Combined|2019-2023
0-19|0.9|1.0|1.0|4017|Incidence|412527765|Bones and Joints|2019-2023
0-19|2.8|2.9|2.9|11777|Incidence|412527765|Brain and Other Nervous System|2019-2023
0-19|1.2|1.3|1.2|5216|Incidence|412527765|Hodgkin Lymphoma|2019-2023
0-19|0.7|0.8|0.7|2922|Incidence|412527765|Kidney and Renal Pelvis|2019-2023
0-19|4.5|4.7|4.6|18743|Incidence|412527765|Leukemia|2019-2023
0-19|1.3|1.3|1.3|5442|Incidence|412527765|Non-Hodgkin Lymphoma|2019-2023
0-19|5.6|5.7|5.6|23459|Incidence|412527765|Other|2019-2023
0-19|1.0|1.1|1.1|4419|Incidence|412527765|Soft Tissue|2019-2023
0-14|4.0|4.3|4.1|2528|Incidence|61339195|Acute Lymphocytic|2020
0-14|0.6|0.8|0.7|424|Incidence|61339195|Acute Myeloid|2020
0-14|16.1|16.8|16.5|10063|Incidence|61339195|All Cancer Sites Combined|2020
0-14|0.6|0.7|0.7|417|Incidence|61339195|Bones and Joints|2020
0-14|3.0|3.3|3.2|1932|Incidence|61339195|Brain and Other Nervous System|2020
0-14|0.5|0.6|0.5|330|Incidence|61339195|Hodgkin Lymphoma|2020
0-14|0.9|1.0|0.9|563|Incidence|61339195|Kidney and Renal Pelvis|2020
0-14|5.0|5.3|5.1|3131|Incidence|61339195|Leukemia|2020
0-14|0.9|1.1|1.0|623|Incidence|61339195|Non-Hodgkin Lymphoma|2020
0-14|3.9|4.2|4.0|2455|Incidence|61339195|Other|2020
0-14|0.9|1.1|1.0|612|Incidence|61339195|Soft Tissue|2020
0-19|3.4|3.7|3.5|2907|Incidence|82886629|Acute Lymphocytic|2020
0-19|0.7|0.8|0.7|610|Incidence|82886629|Acute Myeloid|2020
0-19|17.9|18.4|18.2|15053|Incidence|82886629|All Cancer Sites Combined|2020
0-19|0.8|1.0|0.9|755|Incidence|82886629|Bones and Joints|2020
0-19|2.8|3.1|3.0|2438|Incidence|82886629|Brain and Other Nervous System|2020
0-19|1.1|1.2|1.2|989|Incidence|82886629|Hodgkin Lymphoma|2020
0-19|0.7|0.8|0.8|612|Incidence|82886629|Kidney and Renal Pelvis|2020
0-19|4.5|4.8|4.6|3785|Incidence|82886629|Leukemia|2020
0-19|1.2|1.3|1.2|1029|Incidence|82886629|Non-Hodgkin Lymphoma|2020
0-19|5.4|5.7|5.5|4598|Incidence|82886629|Other|2020
0-19|1.0|1.1|1.0|847|Incidence|82886629|Soft Tissue|2020
0-14|3.9|4.2|4.1|2444|Incidence|60629813|Acute Lymphocytic|2021
0-14|0.6|0.7|0.7|407|Incidence|60629813|Acute Myeloid|2021
0-14|16.4|17.1|16.7|10098|Incidence|60629813|All Cancer Sites Combined|2021
0-14|0.7|0.8|0.8|473|Incidence|60629813|Bones and Joints|2021
0-14|3.2|3.5|3.4|2034|Incidence|60629813|Brain and Other Nervous System|2021
0-14|0.5|0.6|0.5|331|Incidence|60629813|Hodgkin Lymphoma|2021
0-14|0.8|1.0|0.9|543|Incidence|60629813|Kidney and Renal Pelvis|2021
0-14|4.8|5.2|5.0|3016|Incidence|60629813|Leukemia|2021
0-14|1.1|1.3|1.2|729|Incidence|60629813|Non-Hodgkin Lymphoma|2021
0-14|3.7|4.0|3.9|2316|Incidence|60629813|Other|2021
0-14|1.0|1.2|1.1|656|Incidence|60629813|Soft Tissue|2021
0-19|3.4|3.6|3.5|2840|Incidence|82212844|Acute Lymphocytic|2021
0-19|0.7|0.8|0.7|602|Incidence|82212844|Acute Myeloid|2021
0-19|18.3|18.8|18.6|15260|Incidence|82212844|All Cancer Sites Combined|2021
0-19|0.9|1.0|1.0|811|Incidence|82212844|Bones and Joints|2021
0-19|3.0|3.2|3.1|2526|Incidence|82212844|Brain and Other Nervous System|2021
0-19|1.1|1.3|1.2|1023|Incidence|82212844|Hodgkin Lymphoma|2021
0-19|0.7|0.8|0.7|593|Incidence|82212844|Kidney and Renal Pelvis|2021
0-19|4.4|4.7|4.6|3705|Incidence|82212844|Leukemia|2021
0-19|1.3|1.5|1.4|1149|Incidence|82212844|Non-Hodgkin Lymphoma|2021
0-19|5.4|5.7|5.5|4568|Incidence|82212844|Other|2021
0-19|1.0|1.2|1.1|885|Incidence|82212844|Soft Tissue|2021
0-14|3.9|4.3|4.1|2450|Incidence|60216026|Acute Lymphocytic|2022
0-14|0.6|0.8|0.7|424|Incidence|60216026|Acute Myeloid|2022
0-14|16.3|17.0|16.7|9982|Incidence|60216026|All Cancer Sites Combined|2022
0-14|0.7|0.9|0.8|503|Incidence|60216026|Bones and Joints|2022
0-14|3.2|3.5|3.3|1985|Incidence|60216026|Brain and Other Nervous System|2022
0-14|0.5|0.7|0.6|374|Incidence|60216026|Hodgkin Lymphoma|2022
0-14|0.8|0.9|0.9|513|Incidence|60216026|Kidney and Renal Pelvis|2022
0-14|4.9|5.3|5.1|3025|Incidence|60216026|Leukemia|2022
0-14|1.1|1.3|1.2|719|Incidence|60216026|Non-Hodgkin Lymphoma|2022
0-14|3.6|4.0|3.8|2265|Incidence|60216026|Other|2022
0-14|0.9|1.1|1.0|598|Incidence|60216026|Soft Tissue|2022
0-19|3.5|3.7|3.6|2890|Incidence|82113420|Acute Lymphocytic|2022
0-19|0.7|0.8|0.8|632|Incidence|82113420|Acute Myeloid|2022
0-19|18.5|19.1|18.8|15469|Incidence|82113420|All Cancer Sites Combined|2022
0-19|1.0|1.1|1.0|869|Incidence|82113420|Bones and Joints|2022
0-19|2.9|3.1|3.0|2459|Incidence|82113420|Brain and Other Nervous System|2022
0-19|1.2|1.4|1.3|1090|Incidence|82113420|Hodgkin Lymphoma|2022
0-19|0.7|0.8|0.7|584|Incidence|82113420|Kidney and Renal Pelvis|2022
0-19|4.5|4.8|4.7|3783|Incidence|82113420|Leukemia|2022
0-19|1.3|1.5|1.4|1171|Incidence|82113420|Non-Hodgkin Lymphoma|2022
0-19|5.4|5.8|5.6|4665|Incidence|82113420|Other|2022
0-19|1.0|1.1|1.0|848|Incidence|82113420|Soft Tissue|2022
0-14|3.8|4.2|4.0|2379|Incidence|59860111|Acute Lymphocytic|2023
0-14|0.7|0.8|0.7|445|Incidence|59860111|Acute Myeloid|2023
0-14|15.2|15.8|15.5|9216|Incidence|59860111|All Cancer Sites Combined|2023
0-14|0.7|0.8|0.7|454|Incidence|59860111|Bones and Joints|2023
0-14|2.3|2.5|2.4|1440|Incidence|59860111|Brain and Other Nervous System|2023
0-14|0.5|0.7|0.6|364|Incidence|59860111|Hodgkin Lymphoma|2023
0-14|0.8|1.0|0.9|518|Incidence|59860111|Kidney and Renal Pelvis|2023
0-14|4.9|5.2|5.0|2996|Incidence|59860111|Leukemia|2023
0-14|1.0|1.2|1.1|648|Incidence|59860111|Non-Hodgkin Lymphoma|2023
0-14|3.5|3.9|3.7|2194|Incidence|59860111|Other|2023
0-14|0.9|1.1|1.0|602|Incidence|59860111|Soft Tissue|2023
0-19|3.4|3.6|3.5|2817|Incidence|82088184|Acute Lymphocytic|2023
0-19|0.7|0.9|0.8|655|Incidence|82088184|Acute Myeloid|2023
0-19|17.3|17.9|17.6|14564|Incidence|82088184|All Cancer Sites Combined|2023
0-19|0.9|1.0|0.9|776|Incidence|82088184|Bones and Joints|2023
0-19|2.1|2.4|2.3|1832|Incidence|82088184|Brain and Other Nervous System|2023
0-19|1.2|1.3|1.2|1058|Incidence|82088184|Hodgkin Lymphoma|2023
0-19|0.7|0.8|0.7|578|Incidence|82088184|Kidney and Renal Pelvis|2023
0-19|4.5|4.8|4.6|3748|Incidence|82088184|Leukemia|2023
0-19|1.2|1.4|1.3|1094|Incidence|82088184|Non-Hodgkin Lymphoma|2023
0-19|5.3|5.7|5.5|4602|Incidence|82088184|Other|2023
0-19|1.0|1.1|1.1|876|Incidence|82088184|Soft Tissue|2023
0-14|0.2|0.2|0.2|118|Mortality|60879327|Acute Lymphocytic|2018
0-14|0.2|0.2|0.2|127|Mortality|60879327|Acute Myeloid|2018
0-14|1.9|2.1|2.0|1220|Mortality|60879327|All Cancer Sites Combined|2018
0-14|0.1|0.2|0.2|97|Mortality|60879327|Bones and Joints|2018
0-14|0.6|0.7|0.7|409|Mortality|60879327|Brain and Other Nervous System|2018
0-14|~|~|~|~|Mortality|60879327|Hodgkin Lymphoma|2018
0-14|0.0|0.1|0.1|41|Mortality|60879327|Kidney and Renal Pelvis|2018
0-14|0.4|0.5|0.5|297|Mortality|60879327|Leukemia|2018
0-14|0.0|0.1|0.0|29|Mortality|60879327|Non-Hodgkin Lymphoma|2018
0-14|0.3|0.4|0.4|233|Mortality|60879327|Other|2018
0-14|0.1|0.2|0.2|111|Mortality|60879327|Soft Tissue|2018
0-19|0.2|0.3|0.2|196|Mortality|81956393|Acute Lymphocytic|2018
0-19|0.2|0.3|0.2|178|Mortality|81956393|Acute Myeloid|2018
0-19|2.1|2.3|2.2|1841|Mortality|81956393|All Cancer Sites Combined|2018
0-19|0.2|0.3|0.2|195|Mortality|81956393|Bones and Joints|2018
0-19|0.6|0.7|0.7|532|Mortality|81956393|Brain and Other Nervous System|2018
0-19|~|~|~|~|Mortality|81956393|Hodgkin Lymphoma|2018
0-19|0.0|0.1|0.1|50|Mortality|81956393|Kidney and Renal Pelvis|2018
0-19|0.5|0.6|0.6|459|Mortality|81956393|Leukemia|2018
0-19|0.1|0.1|0.1|55|Mortality|81956393|Non-Hodgkin Lymphoma|2018
0-19|0.4|0.5|0.4|346|Mortality|81956393|Other|2018
0-19|0.2|0.3|0.2|192|Mortality|81956393|Soft Tissue|2018
0-14|0.2|0.3|0.2|136|Mortality|60613145|Acute Lymphocytic|2019
0-14|0.2|0.2|0.2|111|Mortality|60613145|Acute Myeloid|2019
0-14|1.7|1.9|1.8|1115|Mortality|60613145|All Cancer Sites Combined|2019
0-14|0.1|0.2|0.1|73|Mortality|60613145|Bones and Joints|2019
0-14|0.6|0.7|0.6|381|Mortality|60613145|Brain and Other Nervous System|2019
0-14|~|~|~|~|Mortality|60613145|Hodgkin Lymphoma|2019
0-14|0.0|0.1|0.1|35|Mortality|60613145|Kidney and Renal Pelvis|2019
0-14|0.4|0.5|0.5|292|Mortality|60613145|Leukemia|2019
0-14|0.0|0.1|0.0|23|Mortality|60613145|Non-Hodgkin Lymphoma|2019
0-14|0.3|0.4|0.4|234|Mortality|60613145|Other|2019
0-14|0.1|0.2|0.1|77|Mortality|60613145|Soft Tissue|2019
0-19|0.2|0.3|0.2|189|Mortality|81679568|Acute Lymphocytic|2019
0-19|0.1|0.2|0.2|139|Mortality|81679568|Acute Myeloid|2019
0-19|2.0|2.2|2.1|1704|Mortality|81679568|All Cancer Sites Combined|2019
0-19|0.2|0.3|0.2|191|Mortality|81679568|Bones and Joints|2019
0-19|0.6|0.7|0.6|513|Mortality|81679568|Brain and Other Nervous System|2019
0-19|~|~|~|~|Mortality|81679568|Hodgkin Lymphoma|2019
0-19|0.0|0.1|0.1|46|Mortality|81679568|Kidney and Renal Pelvis|2019
0-19|0.4|0.5|0.5|405|Mortality|81679568|Leukemia|2019
0-19|0.1|0.1|0.1|65|Mortality|81679568|Non-Hodgkin Lymphoma|2019
0-19|0.4|0.5|0.4|342|Mortality|81679568|Other|2019
0-19|0.1|0.2|0.2|137|Mortality|81679568|Soft Tissue|2019
0-14|0.2|0.2|0.2|118|Mortality|61339195|Acute Lymphocytic|2020
0-14|0.1|0.2|0.2|101|Mortality|61339195|Acute Myeloid|2020
0-14|1.8|2.0|1.9|1153|Mortality|61339195|All Cancer Sites Combined|2020
0-14|0.1|0.2|0.1|90|Mortality|61339195|Bones and Joints|2020
0-14|0.6|0.7|0.6|393|Mortality|61339195|Brain and Other Nervous System|2020
0-14|~|~|~|~|Mortality|61339195|Hodgkin Lymphoma|2020
0-14|0.0|0.1|0.1|39|Mortality|61339195|Kidney and Renal Pelvis|2020
0-14|0.4|0.5|0.5|276|Mortality|61339195|Leukemia|2020
0-14|0.0|0.0|0.0|17|Mortality|61339195|Non-Hodgkin Lymphoma|2020
0-14|0.4|0.5|0.4|244|Mortality|61339195|Other|2020
0-14|0.1|0.2|0.2|93|Mortality|61339195|Soft Tissue|2020
0-19|0.2|0.2|0.2|178|Mortality|82886629|Acute Lymphocytic|2020
0-19|0.1|0.2|0.2|133|Mortality|82886629|Acute Myeloid|2020
0-19|2.0|2.1|2.0|1702|Mortality|82886629|All Cancer Sites Combined|2020
0-19|0.2|0.3|0.2|196|Mortality|82886629|Bones and Joints|2020
0-19|0.6|0.7|0.6|522|Mortality|82886629|Brain and Other Nervous System|2020
0-19|~|~|~|~|Mortality|82886629|Hodgkin Lymphoma|2020
0-19|0.0|0.1|0.1|50|Mortality|82886629|Kidney and Renal Pelvis|2020
0-19|0.4|0.5|0.5|392|Mortality|82886629|Leukemia|2020
0-19|0.0|0.1|0.0|33|Mortality|82886629|Non-Hodgkin Lymphoma|2020
0-19|0.4|0.5|0.4|348|Mortality|82886629|Other|2020
0-19|0.2|0.2|0.2|154|Mortality|82886629|Soft Tissue|2020
0-14|0.2|0.2|0.2|666|Mortality|301743285|Acute Lymphocytic|2020-2024
0-14|0.1|0.2|0.2|481|Mortality|301743285|Acute Myeloid|2020-2024
0-14|1.9|2.0|1.9|5758|Mortality|301743285|All Cancer Sites Combined|2020-2024
0-14|0.1|0.2|0.1|439|Mortality|301743285|Bones and Joints|2020-2024
0-14|0.6|0.7|0.6|1943|Mortality|301743285|Brain and Other Nervous System|2020-2024
0-14|~|~|~|~|Mortality|301743285|Hodgkin Lymphoma|2020-2024
0-14|0.1|0.1|0.1|198|Mortality|301743285|Kidney and Renal Pelvis|2020-2024
0-14|0.4|0.5|0.5|1404|Mortality|301743285|Leukemia|2020-2024
0-14|0.0|0.1|0.0|131|Mortality|301743285|Non-Hodgkin Lymphoma|2020-2024
0-14|0.4|0.4|0.4|1169|Mortality|301743285|Other|2020-2024
0-14|0.1|0.2|0.2|469|Mortality|301743285|Soft Tissue|2020-2024
0-19|0.2|0.3|0.2|1002|Mortality|411375042|Acute Lymphocytic|2020-2024
0-19|0.2|0.2|0.2|708|Mortality|411375042|Acute Myeloid|2020-2024
0-19|2.1|2.2|2.1|8826|Mortality|411375042|All Cancer Sites Combined|2020-2024
0-19|0.2|0.3|0.3|1096|Mortality|411375042|Bones and Joints|2020-2024
0-19|0.6|0.6|0.6|2558|Mortality|411375042|Brain and Other Nervous System|2020-2024
0-19|0.0|0.0|0.0|32|Mortality|411375042|Hodgkin Lymphoma|2020-2024
0-19|0.1|0.1|0.1|246|Mortality|411375042|Kidney and Renal Pelvis|2020-2024
0-19|0.5|0.5|0.5|2090|Mortality|411375042|Leukemia|2020-2024
0-19|0.0|0.1|0.1|230|Mortality|411375042|Non-Hodgkin Lymphoma|2020-2024
0-19|0.4|0.4|0.4|1745|Mortality|411375042|Other|2020-2024
0-19|0.2|0.2|0.2|829|Mortality|411375042|Soft Tissue|2020-2024
0-14|0.2|0.3|0.2|134|Mortality|60629813|Acute Lymphocytic|2021
0-14|0.1|0.2|0.1|82|Mortality|60629813|Acute Myeloid|2021
0-14|1.8|2.0|1.9|1130|Mortality|60629813|All Cancer Sites Combined|2021
0-14|0.1|0.1|0.1|73|Mortality|60629813|Bones and Joints|2021
0-14|0.6|0.7|0.6|391|Mortality|60629813|Brain and Other Nervous System|2021
0-14|~|~|~|~|Mortality|60629813|Hodgkin Lymphoma|2021
0-14|0.0|0.1|0.1|39|Mortality|60629813|Kidney and Renal Pelvis|2021
0-14|0.4|0.5|0.4|267|Mortality|60629813|Leukemia|2021
0-14|0.0|0.1|0.1|32|Mortality|60629813|Non-Hodgkin Lymphoma|2021
0-14|0.3|0.4|0.4|231|Mortality|60629813|Other|2021
0-14|0.1|0.2|0.2|96|Mortality|60629813|Soft Tissue|2021
0-19|0.2|0.3|0.2|192|Mortality|82212844|Acute Lymphocytic|2021
0-19|0.1|0.2|0.2|124|Mortality|82212844|Acute Myeloid|2021
0-19|2.0|2.2|2.1|1722|Mortality|82212844|All Cancer Sites Combined|2021
0-19|0.2|0.3|0.2|202|Mortality|82212844|Bones and Joints|2021
0-19|0.6|0.7|0.6|503|Mortality|82212844|Brain and Other Nervous System|2021
0-19|~|~|~|~|Mortality|82212844|Hodgkin Lymphoma|2021
0-19|0.0|0.1|0.1|48|Mortality|82212844|Kidney and Renal Pelvis|2021
0-19|0.4|0.5|0.5|395|Mortality|82212844|Leukemia|2021
0-19|0.0|0.1|0.1|54|Mortality|82212844|Non-Hodgkin Lymphoma|2021
0-19|0.4|0.5|0.4|346|Mortality|82212844|Other|2021
0-19|0.2|0.2|0.2|167|Mortality|82212844|Soft Tissue|2021
0-14|0.2|0.3|0.2|133|Mortality|60216026|Acute Lymphocytic|2022
0-14|0.1|0.2|0.2|105|Mortality|60216026|Acute Myeloid|2022
0-14|1.8|2.0|1.9|1141|Mortality|60216026|All Cancer Sites Combined|2022
0-14|0.1|0.2|0.1|87|Mortality|60216026|Bones and Joints|2022
0-14|0.5|0.7|0.6|367|Mortality|60216026|Brain and Other Nervous System|2022
0-14|~|~|~|~|Mortality|60216026|Hodgkin Lymphoma|2022
0-14|0.1|0.1|0.1|43|Mortality|60216026|Kidney and Renal Pelvis|2022
0-14|0.4|0.5|0.5|293|Mortality|60216026|Leukemia|2022
0-14|0.0|0.1|0.0|23|Mortality|60216026|Non-Hodgkin Lymphoma|2022
0-14|0.3|0.4|0.4|223|Mortality|60216026|Other|2022
0-14|0.1|0.2|0.2|103|Mortality|60216026|Soft Tissue|2022
0-19|0.2|0.3|0.3|212|Mortality|82113420|Acute Lymphocytic|2022
0-19|0.2|0.2|0.2|157|Mortality|82113420|Acute Myeloid|2022
0-19|2.0|2.2|2.1|1772|Mortality|82113420|All Cancer Sites Combined|2022
0-19|0.2|0.3|0.3|235|Mortality|82113420|Bones and Joints|2022
0-19|0.5|0.6|0.6|480|Mortality|82113420|Brain and Other Nervous System|2022
0-19|~|~|~|~|Mortality|82113420|Hodgkin Lymphoma|2022
0-19|0.0|0.1|0.1|49|Mortality|82113420|Kidney and Renal Pelvis|2022
0-19|0.5|0.6|0.5|450|Mortality|82113420|Leukemia|2022
0-19|0.0|0.1|0.0|39|Mortality|82113420|Non-Hodgkin Lymphoma|2022
0-19|0.4|0.4|0.4|329|Mortality|82113420|Other|2022
0-19|0.2|0.2|0.2|180|Mortality|82113420|Soft Tissue|2022
0-14|0.2|0.3|0.2|140|Mortality|59860111|Acute Lymphocytic|2023
0-14|0.1|0.2|0.2|97|Mortality|59860111|Acute Myeloid|2023
0-14|1.8|2.1|1.9|1166|Mortality|59860111|All Cancer Sites Combined|2023
0-14|0.1|0.2|0.2|101|Mortality|59860111|Bones and Joints|2023
0-14|0.6|0.7|0.7|393|Mortality|59860111|Brain and Other Nervous System|2023
0-14|~|~|~|~|Mortality|59860111|Hodgkin Lymphoma|2023
0-14|0.0|0.1|0.1|38|Mortality|59860111|Kidney and Renal Pelvis|2023
0-14|0.4|0.5|0.5|291|Mortality|59860111|Leukemia|2023
0-14|0.0|0.1|0.0|24|Mortality|59860111|Non-Hodgkin Lymphoma|2023
0-14|0.3|0.4|0.4|234|Mortality|59860111|Other|2023
0-14|0.1|0.2|0.1|84|Mortality|59860111|Soft Tissue|2023
0-19|0.2|0.3|0.3|220|Mortality|82088184|Acute Lymphocytic|2023
0-19|0.2|0.2|0.2|157|Mortality|82088184|Acute Myeloid|2023
0-19|2.1|2.3|2.2|1829|Mortality|82088184|All Cancer Sites Combined|2023
0-19|0.2|0.3|0.3|231|Mortality|82088184|Bones and Joints|2023
0-19|0.6|0.7|0.6|533|Mortality|82088184|Brain and Other Nervous System|2023
0-19|~|~|~|~|Mortality|82088184|Hodgkin Lymphoma|2023
0-19|0.0|0.1|0.1|47|Mortality|82088184|Kidney and Renal Pelvis|2023
0-19|0.5|0.6|0.5|453|Mortality|82088184|Leukemia|2023
0-19|0.0|0.1|0.1|52|Mortality|82088184|Non-Hodgkin Lymphoma|2023
0-19|0.4|0.5|0.4|350|Mortality|82088184|Other|2023
0-19|0.2|0.2|0.2|159|Mortality|82088184|Soft Tissue|2023
0-14|0.2|0.3|0.2|141|Mortality|59698140|Acute Lymphocytic|2024
0-14|0.1|0.2|0.2|96|Mortality|59698140|Acute Myeloid|2024
0-14|1.8|2.1|2.0|1168|Mortality|59698140|All Cancer Sites Combined|2024
0-14|0.1|0.2|0.1|88|Mortality|59698140|Bones and Joints|2024
0-14|0.6|0.7|0.7|399|Mortality|59698140|Brain and Other Nervous System|2024
0-14|~|~|~|~|Mortality|59698140|Hodgkin Lymphoma|2024
0-14|0.0|0.1|0.1|39|Mortality|59698140|Kidney and Renal Pelvis|2024
0-14|0.4|0.5|0.5|277|Mortality|59698140|Leukemia|2024
0-14|0.0|0.1|0.1|35|Mortality|59698140|Non-Hodgkin Lymphoma|2024
0-14|0.4|0.5|0.4|237|Mortality|59698140|Other|2024
0-14|0.1|0.2|0.2|93|Mortality|59698140|Soft Tissue|2024
0-19|0.2|0.3|0.2|200|Mortality|82073965|Acute Lymphocytic|2024
0-19|0.1|0.2|0.2|137|Mortality|82073965|Acute Myeloid|2024
0-19|2.1|2.3|2.2|1801|Mortality|82073965|All Cancer Sites Combined|2024
0-19|0.2|0.3|0.3|232|Mortality|82073965|Bones and Joints|2024
0-19|0.6|0.7|0.6|520|Mortality|82073965|Brain and Other Nervous System|2024
0-19|~|~|~|~|Mortality|82073965|Hodgkin Lymphoma|2024
0-19|0.0|0.1|0.1|52|Mortality|82073965|Kidney and Renal Pelvis|2024
0-19|0.4|0.5|0.5|400|Mortality|82073965|Leukemia|2024
0-19|0.0|0.1|0.1|52|Mortality|82073965|Non-Hodgkin Lymphoma|2024
0-19|0.4|0.5|0.5|372|Mortality|82073965|Other|2024
0-19|0.2|0.2|0.2|169|Mortality|82073965|Soft Tissue|2024
